Benign neoplasm: Transverse colon

CD2_BENIGN_TRANSVERSE_COLON

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — D12.3& Hospital discharge: ICD-8 — 21134 Cause of death: ICD-10 — D12.3& Cause of death: ICD-8 — 21134 2 out of 7 registries used, show all original rules.	3677
4. Check minimum number of events None	3677
5. Include endpoints None	3677
6. Filter based on genotype QC (FinnGen only)	3677

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: D12
Name in latin: Neoplasma benignum coli transversi

NAME	CD2_BENIGN_TRANSVERSE_COLON
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	D123
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	21134
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	D123
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	21134
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Benign neoplasm: Transverse colon based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Benign neoplasm: Transverse colon

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	16587	7441	9089
Only index persons	15795	7174	8621
Unadjusted period prevalence (%)
Whole population	0.23	0.21	0.25
Only index persons	0.30	0.26	0.33
Median age at first event (years)
Whole population	68.07	67.76	68.33
Only index persons	67.93	67.60	68.21

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3677	1640	2037
Unadjusted period prevalence (%)	0.75	0.56	0.90
Median age at first event (years)	67.58	66.53	68.44

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3139: Matched controls
31389

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

D12.8

ICD-10 Finland

Benign neoplasm: Rectum

12.9

323.0

626

596

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

23.2

323.0

1206

823

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

24.6

323.0

769

408

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

4503599627370496.0

323.0

3121

UJF32

NOMESCO Finland

Coloscopy

13.9

323.0

2396

5897

D12.4

ICD-10 Finland

Benign neoplasm: Descending colon

27.2

323.0

456

195

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

17.5

323.0

792

593

UJF30

NOMESCO Finland

Ileoscopy through colon

7.0

307.8

867

1630

D12.0

ICD-10 Finland

Benign neoplasm: Caecum

18.7

306.9

488

305

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

4.8

303.2

1286

3936

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

20.2

271.6

419

237

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

8.7

271.2

635

887

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

3.6

239.0

1559

6687

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

3.4

87.0

468

1526

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

3.0

83.8

543

2020

A06AC01

ATC

ispaghula (psylla seeds); oral

2.3

82.6

980

5148

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.2

81.3

1221

7141

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.0

74.4

1678

11463

Z01.8

ICD-10 Finland

Other specified special examinations

2.2

64.6

824

4382

A02BC02

ATC

pantoprazole; systemic

1.9

59.1

2157

16863

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

3.1

59.1

350

1206

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

2.9

58.5

384

1417

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.9

52.9

356

1331

WX002

NOMESCO Finland

Sedation and analgesia

2.0

52.5

787

4419

N02BE01

ATC

paracetamol; systemic, rectal

2.2

51.6

2746

23918

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.2

46.1

523

2586

D64.9

ICD-10 Finland

Anaemia, unspecified

2.4

45.6

450

2083

A02BC05

ATC

esomeprazole; systemic

1.7

45.6

1329

9313

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

3.0

45.0

274

956

K63.5

ICD-10 Finland

Polyp of colon

7.5

44.5

108

149

D37.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Colon

6.2

44.4

123

204

UJH02

NOMESCO Finland

Anoscopy

3.6

42.2

203

595

JFB31

NOMESCO Finland

Laparoscopic right hemicolectomy

7.1

41.9

105

152

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.3

41.3

413

1917

A02BC03

ATC

lansoprazole; oral

1.8

40.9

1015

6703

K92.1

ICD-10 Finland

Melaena

2.9

40.1

264

968

JFA42

NOMESCO Finland

Endoscopic injection in colon

16.2

40.0

D12.7

ICD-10 Finland

Benign neoplasm: Rectosigmoid junction

7.3

39.6

136

JN4BD

NOMESCO Finland

Extensive body CT

2.2

38.7

462

2322

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.2

37.7

428

2104

H02AB06

ATC

prednisolone; systemic

1.6

37.1

1483

11133

R06.0

ICD-10 Finland

Dyspnoea

1.8

37.1

860

5528

J01DB01

ATC

cefalexin; oral

1.8

36.9

2490

21537

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.4

36.6

339

1508

AA1AD

NOMESCO Finland

CT of head and brain

1.7

35.8

861

5584

N02AX02

ATC

tramadol; systemic, rectal

1.6

35.6

1397

10396

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.9

35.4

602

3479

JFA45

NOMESCO Finland

Endoscopic contact coagulation in colon

10.8

34.6

TPH04

NOMESCO Finland

Cathetrisation of vein

1.8

34.2

722

4484

C03CA01

ATC

furosemide; systemic

1.7

33.8

1039

7213

R03AC02

ATC

salbutamol; inhalant

1.6

33.7

1512

11587

Z98.0

ICD-10 Finland

Intestinal bypass and anastomosis status

12.8

33.0

B01AB05

ATC

enoxaparin; parenteral

1.6

32.7

1055

7406

R07.4

ICD-10 Finland

Chest pain, unspecified

1.7

32.0

913

6186

P01AB01

ATC

metronidazole; oral, rectal

1.6

31.1

1135

8196

JFA52

NOMESCO Finland

Other endoscopic haemostatic procedure in colon

15.2

30.8

C07AB07

ATC

bisoprolol; oral

1.6

30.8

1612

12709

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.9

30.6

553

3246

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.7

30.2

855

5764

JN3AD

NOMESCO Finland

Abdominal CT examination

2.3

29.8

300

1386

J01CA04

ATC

amoxicillin; systemic

1.6

29.3

2324

20113

XF400

NOMESCO Finland

ECG with 12 standard connections

1.8

28.9

588

3583

A10BA02

ATC

metformin; oral

1.6

28.3

956

6733

A07EC02

ATC

mesalazine; oral, rectal

2.7

27.5

199

772

D01

ICPC

Abdominal pain/cramps general

2.1

27.1

318

1574

I10

ICD-10 Finland

Essential (primary) hypertension

1.5

26.9

1975

16571

N03AX16

ATC

pregabalin; oral

1.7

26.9

741

4931

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.1

26.8

340

1738

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.6

26.8

818

5591

103

Kela drug reimbursment

Diabetes, insulin-treated

1.6

26.8

916

6446

WX408

NOMESCO Finland

General anesthesy, balanced

1.6

26.2

859

5975

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

3.2

26.1

141

452

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.5

25.5

1039

7613

G47.3

ICD-10 Finland

Sleep apnoea

1.7

25.1

674

4440

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

2.9

25.0

157

558

J01AA02

ATC

doxycycline; systemic

1.5

24.9

2337

20514

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

24.7

1159

8757

J01MA02

ATC

ciprofloxacin; systemic

1.5

24.7

1234

9455

D13.1

ICD-10 Finland

Benign neoplasm: Stomach

3.6

24.6

112

315

J45.9

ICD-10 Finland

Asthma, unspecified

1.7

24.5

544

3390

R01AD09

ATC

mometasone; nasal

1.5

23.8

1191

9106

E0000UV

ATC

1.5

23.4

1093

8219

S18

ICPC

Laceration/cut

1.5

23.3

1356

10683

R4110

NOMESCO Finland

Physiotherapy

1.6

23.3

832

5879

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.7

23.3

579

3723

K29.3

ICD-10 Finland

Chronic superficial gastritis

3.0

23.2

141

491

D12.9

ICD-10 Finland

Benign neoplasm: Anus and anal canal

7.2

22.6

D12.1

ICD-10 Finland

Benign neoplasm: Appendix

14.4

22.1

M54.5

ICD-10 Finland

Low back pain

1.5

22.0

894

6494

JFA55

NOMESCO Finland

Other endoscopic procedure using diathermy or heat in colon

9.1

22.0

N03AX12

ATC

gabapentin; oral

1.7

22.0

482

2980

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.5

21.9

813

5784

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

2.2

21.8

238

1137

SPAT1249

SPAT

Treatment-related counselling outside office

1.5

21.7

1177

9095

D13.2

ICD-10 Finland

Benign neoplasm: Duodenum

6.6

21.5

K51.5

ICD-10 Finland

Left sided colitis

3.6

21.3

269

C05AA08

ATC

fluocortolone; rectal, topical

1.7

21.2

456

2801

C10AA05

ATC

atorvastatin; oral

1.4

21.1

1311

10396

JFB30

NOMESCO Finland

Right hemicolectomy

4.1

21.1

206

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

2.3

21.0

199

893

M79.6

ICD-10 Finland

Pain in limb

1.5

20.8

1029

7781

SPAT1263

SPAT

Sampling

1.4

20.8

1250

9838

R03BB04

ATC

tiotropium bromide; inhalant

1.8

20.8

363

2085

SPAT1104

SPAT

Monitoring of emergency patient

2.1

20.7

249

1244

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

20.6

1377

11060

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.6

20.5

538

3502

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.9

20.4

313

1719

T90

ICPC

Diabetes non-insulin dependent

1.5

20.4

780

5575

UJF92

NOMESCO Finland

Capsular endoscopy

3.7

20.4

248

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.7

20.3

463

2896

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.9

20.1

334

1887

WX722

NOMESCO Finland

PEEP

2.4

20.0

180

786

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.4

19.8

1329

10653

JN4AD

NOMESCO Finland

Body CT examination

1.9

19.6

293

1592

I50.9

ICD-10 Finland

Heart failure, unspecified

1.7

19.6

459

2888

I84.5

ICD-10 Finland

External hemorrhoids without complication

3.0

19.4

117

405

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.4

19.4

174

759

WX892

NOMESCO Finland

Monitored bed care

2.0

19.4

272

1443

R03BA02

ATC

budesonide; inhalant

1.7

19.4

482

3085

J45

ICD-10 Finland

Asthma

1.9

19.3

281

1512

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.9

19.3

298

1638

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.6

19.2

596

4043

C08CA01

ATC

amlodipine; oral

1.4

19.1

1187

9352

R53

ICD-10 Finland

Malaise and fatigue

1.6

19.1

580

3914

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.5

19.1

796

5788

WX302

NOMESCO Finland

Thoracal epidural anesthesy

2.2

19.0

191

881

B01AA03

ATC

warfarin; systemic

1.5

19.0

710

5034

A02BC04

ATC

rabeprazole; oral

2.0

18.8

254

1329

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.0

18.8

266

1418

L04AX01

ATC

azathioprine; systemic

2.6

18.8

145

583

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

18.6

1035

7975

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

4.2

18.5

173

N06AX11

ATC

mirtazapine; oral

1.5

18.5

886

6624

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.6

18.3

522

3462

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.5

18.3

722

5176

K59.09

ICD-10 Finland

Constipation, unspecified

2.1

18.2

219

1094

ZX120

NOMESCO Finland

Intravenous

1.8

18.1

310

1766

WX110

NOMESCO Finland

Local anesthesy

1.4

18.0

1883

16240

H02AB07

ATC

prednisone; oral

1.7

18.0

430

2718

A02BC01

ATC

omeprazole; systemic

1.5

17.9

838

6227

ICD-10 Finland

3.1

17.9

100

331

A02BA02

ATC

ranitidine; systemic

1.6

17.9

610

4225

C18.41

ICD-10 Finland

Malignant tumor of the transverse colon invasive carcinoma

9.1

17.9

TPH07

NOMESCO Finland

Cathetrisation of artery

1.8

17.8

348

2068

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.8

17.7

311

1788

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.9

17.7

294

1659

D11

ICPC

Diarrhoea

1.9

17.5

269

1476

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

2.9

17.3

107

379

M04AA01

ATC

allopurinol; systemic

1.6

17.3

460

2993

SAA02

NOMESCO Finland

Basic examination of mouth

1.4

17.2

1643

13895

B80

ICPC

Iron deficiency anaemia

3.6

17.0

218

TK800

NOMESCO Finland

Hemodialysis

3.1

16.9

300

R03AK07

ATC

formoterol and budesonide; inhalant

1.6

16.8

502

3359

M10.9

ICD-10 Finland

Gout, unspecified

1.9

16.8

248

1341

R03DC03

ATC

montelukast; oral

1.7

16.8

411

2614

A04

ICPC

Weakness/tiredness general

1.7

16.7

387

2420

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.0

16.7

217

1119

N06AB10

ATC

escitalopram; oral

1.6

16.6

457

2997

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.6

16.6

421

2705

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.4

16.4

936

7208

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

2.7

16.4

114

434

D06

ICPC

Abdominal pain localized other

2.0

16.3

218

1135

N05BA04

ATC

oxazepam; oral

1.5

16.2

672

4854

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.4

16.1

1192

9612

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.7

16.0

361

2242

UKC02

NOMESCO Finland

Cystoscopy

1.5

15.9

568

3965

J02AC01

ATC

fluconazole; systemic

1.4

15.9

924

7132

J01DA01

ATC

[U] cefalexin; systemic

1.4

15.7

1756

15134

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.7

15.6

328

1992

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.9

15.5

234

1277

K29.7

ICD-10 Finland

Gastritis, unspecified

2.4

15.3

133

571

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

2.7

15.2

102

380

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

2.9

15.1

322

A10BH01

ATC

sitagliptin; oral

1.7

15.1

328

2012

207

Kela drug reimbursment

Chronic arrhythmias

1.5

15.1

507

3485

ZXA00

NOMESCO Finland

Right side

1.4

15.1

836

6383

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

2.6

15.1

110

432

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.6

15.0

394

2548

J01FA06

ATC

roxithromycin; oral

1.4

14.9

1118

9002

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

14.8

912

7091

N06AB04

ATC

citalopram; systemic

1.5

14.7

579

4128

E66.00

ICD-10 Finland

Metabolic syndrome

2.1

14.7

165

803

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.4

14.7

978

7712

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.5

14.6

484

3316

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.4

14.6

735

5506

K59.0

ICD-10 Finland

Constipation

2.0

14.5

179

901

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.5

14.5

487

3345

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

3.3

14.5

220

8140/3-C18.9

ICD-O-3

Adenocarcinoma, NOS, of colon, NOS

6.7

14.5

A07EA06

ATC

budesonide; oral, local oral

2.6

14.5

105

409

R51.80

ICD-10 Finland

Headache

1.7

14.4

344

2167

K02.1

ICD-10 Finland

Caries of dentine

1.3

14.4

1415

11882

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.5

14.4

513

3574

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.7

14.4

318

1963

GD1AD

NOMESCO Finland

Thorax CT examination

2.2

14.3

155

739

JGA05

NOMESCO Finland

Endoscopic polypectomy in rectum

6.0

14.3

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.6

14.3

386

2510

SAA01

NOMESCO Finland

Simple examination of mouth

1.3

14.2

1819

15899

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.9

14.2

198

1050

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.5

14.2

494

3421

H02AB04

ATC

methylprednisolone; systemic

1.6

14.2

411

2725

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.1

14.1

152

726

JFB43

NOMESCO Finland

Left hemicolectomy

5.2

14.1

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.5

13.9

636

4670

205

Kela drug reimbursment

Chronic hypertension

1.4

13.8

926

7294

J45.1

ICD-10 Finland

Nonallergic asthma

1.9

13.7

206

1122

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.3

13.7

1354

11344

K55.2

ICD-10 Finland

Angiodysplasia of colon

5.5

13.7

A10BG03

ATC

pioglitazone; oral

2.6

13.7

374

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.1

13.7

148

706

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.9

13.7

213

1175

K59.1

ICD-10 Finland

Functional diarrhoea

2.1

13.6

152

735

SPAT1097

SPAT

Recording of ECG

1.5

13.6

476

3301

C18.40

ICD-10 Finland

Malignant tumor of the transverse colon without histology

10.1

13.4

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

1.9

13.4

186

984

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.2

13.4

134

617

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

13.4

561

4041

N05CF01

ATC

zopiclone; oral

1.4

13.4

935

7404

C18.01

ICD-10 Finland

Malignant tumor of the caecum invasive carcinoma

4.4

13.4

107

R02

ICPC

Shortness of breath/dyspnoea

1.6

13.3

361

2352

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.3

13.3

128

579

Z80.0

ICD-10 Finland

Family history of malignant neoplasm of digestive organs

6.2

13.3

C03DA01

ATC

spironolactone; oral

1.6

13.3

348

2246

8140/3-C18.4

ICD-O-3

Adenocarcinoma, NOS, of transverse colon

8.1

13.3

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

3.8

13.3

151

G44.2

ICD-10 Finland

Tension-type headache

1.6

13.2

322

2041

C18.42

ICD-10 Finland

Malignant tumor of the transverse colon carcinoma of the adenoma

40.2

13.1

R05

ICD-10 Finland

Cough

1.5

13.1

549

3952

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.7

13.0

303

1894

C18.21

ICD-10 Finland

Malignant tumor of the ascending colon invasive carcinoma

4.5

13.0

101

A03FA02

ATC

cisapride; oral, rectal

1.8

12.9

229

1320

M48.0

ICD-10 Finland

Spinal stenosis

1.6

12.9

392

2626

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

2.7

12.9

331

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.2

12.8

135

638

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

2.1

12.8

153

761

A10AE04

ATC

insulin glargine; parenteral

1.7

12.8

290

1800

K51.3

ICD-10 Finland

Ulcerative (chronic) rectosigmoiditis

3.3

12.8

198

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.5

12.8

471

3299

C18.72

ICD-10 Finland

Malignant tumor of sigmoid carcinoma of adenoma

6.6

12.8

G04CA02

ATC

tamsulosin; oral

1.4

12.8

818

6375

XF404

NOMESCO Finland

Ambulatory ECG

1.7

12.7

299

1873

JFB40

NOMESCO Finland

Resection of transverse colon

14.1

12.7

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.8

12.7

205

1144

C18.00

ICD-10 Finland

Malignant tumor of the caecum without histology

5.1

12.7

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

3.0

12.7

248

R06AE07

ATC

cetirizine; oral

1.3

12.7

1081

8824

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.7

12.7

320

L01BC06

ATC

capecitabine; oral

2.2

12.6

123

560

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

3.7

12.6

148

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.4

12.6

882

6973

SPAT1101

SPAT

Orthostatic test

2.0

12.5

160

820

21134

ICD-8 Finland

Benign neoplasm of other parts of digestive system, Coli transversi (flexuris hepatica et splenica inclusis)

+∞

12.5

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.1

12.5

142

694

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.1

12.5

146

721

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.5

12.4

484

3432

R96

ICPC

Asthma

1.7

12.3

246

1472

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.9

12.3

190

1043

A10BH05

ATC

linagliptin; oral

2.0

12.3

162

839

N17

ICPC

Vertigo/dizziness

1.6

12.2

319

2057

A98

ICPC

Health maint/preventive medicine

1.6

12.2

2865

27292

RD211

NOMESCO Finland

0.2

12.2

689

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.4

12.2

657

4962

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.4

12.2

710

5437

C10AA01

ATC

simvastatin; oral

1.3

12.1

1453

12447

K64.0

ICD-10 Finland

First degree haemorrhoids

3.7

12.1

143

XKD00

NOMESCO Finland

Uroflowmetry

1.4

12.1

582

4302

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

2.3

12.1

107

468

R13

ICD-10 Finland

Dysphagia

1.8

12.0

205

1168

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

2.3

12.0

112

502

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.7

12.0

261

1599

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.6

12.0

321

2083

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.0

12.0

147

742

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

1.8

12.0

220

1282

K29.8

ICD-10 Finland

Duodenitis

4.0

11.9

120

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

1.9

11.9

177

960

-60

ICPC

Result test/procedure

1.9

11.9

187

1038

C20.92

ICD-10 Finland

Malignant tumor of the rectum carcinoma of the adenoma

4.8

11.7

R03AC03

ATC

terbutaline; inhalant

1.6

11.7

354

2367

A01

ICPC

Pain general/multiple sites

1.7

11.7

225

1330

K62.1

ICD-10 Finland

Rectal polyp

3.8

11.7

132

SPAT1254

SPAT

Administration of medicine

1.5

11.7

418

2904

E66.9

ICD-10 Finland

Obesity, unspecified

2.6

11.7

342

R03BA01

ATC

beclometasone; inhalant

1.5

11.6

373

2527

K85

ICPC

Elevated blood pressure

1.5

11.6

450

3183

J01MA12

ATC

levofloxacin; systemic

1.4

11.6

573

4254

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

11.6

1188

9932

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

2.0

11.5

150

778

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.5

11.5

440

3103

R60.0

ICD-10 Finland

Localized oedema

1.6

11.5

335

2224

J01FF01

ATC

clindamycin; systemic

1.4

11.4

747

5821

E66.01

ICD-10 Finland

Obesity due to excess calories

1.9

11.4

172

940

A06AD11

ATC

lactulose; oral

1.5

11.4

431

3033

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.5

11.4

498

3610

C09CA01

ATC

losartan; oral

1.4

11.3

745

5812

B82

ICPC

Anaemia other/unspecified

2.5

11.3

355

Z01.7

ICD-10 Finland

Laboratory examination

1.6

11.2

298

1931

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.6

11.2

335

2235

C10AC01

ATC

colestyramine; oral

2.6

11.2

325

N05AH04

ATC

quetiapine; oral

1.5

11.1

359

2437

A46

ICD-10 Finland

Erysipelas

1.5

11.1

425

2994

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.5

11.1

422

2971

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.5

11.1

445

3170

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.3

11.1

1409

12114

L17

ICPC

Foot/toe symptom/complaint

1.4

11.1

715

5561

D12

ICPC

Constipation

2.2

11.0

115

542

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.5

11.0

429

3038

R03AC13

ATC

formoterol; inhalant

2.0

11.0

142

734

E66.8

ICD-10 Finland

Other obesity

2.1

11.0

120

580

B01AF02

ATC

apixaban; oral

1.6

11.0

322

2138

N06AX21

ATC

duloxetine; oral

1.6

10.9

260

1636

J20

ICD-10 Finland

Acute bronchitis

1.7

10.9

252

1574

K64.9

ICD-10 Finland

Haemorrhoids, unspecified

3.0

10.8

212

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

2.9

10.7

219

WZA90

NOMESCO Finland

Other doctors statement

1.4

10.7

571

4288

JFB51

NOMESCO Finland

Other laparoscopic resection of colon

21.5

10.7

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

10.7

924

7512

R05FB02

ATC

cough suppressants and expectorants

1.3

10.7

1053

8728

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

2.1

10.6

114

544

R42

ICD-10 Finland

Dizziness and giddiness

1.4

10.6

617

4711

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.8

10.6

197

1152

R01AD08

ATC

fluticasone; nasal

1.4

10.5

680

5284

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.6

10.5

308

2046

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

3.0

10.5

204

C18.20

ICD-10 Finland

Malignant tumor of the ascending colon without histology

4.3

10.5

M54.4

ICD-10 Finland

Lumbago with sciatica

1.5

10.5

410

2905

M70.6

ICD-10 Finland

Trochanteric bursitis

1.5

10.5

328

2210

A07AA02

ATC

nystatin; oral

1.8

10.4

184

1061

A05

ICPC

Feeling ill

2.1

10.4

120

590

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

2.3

10.4

429

ZXA05

NOMESCO Finland

Left side

1.3

10.4

751

5937

SFA00

NOMESCO Finland

Small filling

1.5

10.4

314

2102

C01DA14

ATC

isosorbide mononitrate; oral

1.4

10.4

490

3602

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.7

10.3

229

1414

R03BA08

ATC

ciclesonide; inhalant

1.7

10.3

207

1240

JFB41

NOMESCO Finland

Laparoscopic resection of transverse colon

32.6

10.3

M25.5

ICD-10 Finland

Pain in joint

1.4

10.3

695

5435

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.5

10.3

362

2505

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.7

10.3

215

1304

Z01.2

ICD-10 Finland

Dental examination

1.3

10.3

989

8158

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.1

10.3

117

576

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.6

10.3

244

1534

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.4

10.2

449

3252

I84

ICD-10 Finland

Hemorrhoids

2.3

10.2

398

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.8

10.2

169

953

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.7

10.2

213

1293

J01CE02

ATC

phenoxymethylpenicillin; oral

1.3

10.2

1792

15997

M79.1

ICD-10 Finland

Myalgia

1.5

10.1

307

2055

R4120

NOMESCO Finland

Occupational therapy

1.8

10.1

177

1019

SPAT1301

SPAT

No procedures

1.3

10.1

899

7331

K03.65

ICD-10 Finland

Deposits [accretions] on teeth betel

1.4

10.1

473

3472

8140/3-C18.0

ICD-O-3

Adenocarcinoma, NOS, of cecum

5.0

10.0

SPAT1325

SPAT

Vaccination

1.3

10.0

1038

8646

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.5

9.9

312

2105

WX290

NOMESCO Finland

Other blockade of nerve

1.3

9.9

949

7810

A07EA02

ATC

hydrocortisone; rectal

2.6

9.9

279

R03DA04

ATC

theophylline; systemic, rectal

1.9

9.9

151

827

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.3

9.9

987

8173

SPAT1210

SPAT

Application of cast or individual aid

2.0

9.9

119

600

R11

ICD-10 Finland

Nausea and vomiting

1.7

9.8

201

1213

C08CA13

ATC

lercanidipine; oral

1.5

9.8

403

2877

8140/3-C18.2

ICD-O-3

Adenocarcinoma, NOS, of ascending colon

4.7

9.8

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.4

9.8

326

A06AC51

ATC

ispaghula, combinations; systemic

1.9

9.8

142

766

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.8

9.7

159

892

A91

ICPC

Abnormal result investigation NOS

1.9

9.7

130

682

M01AH05

ATC

etoricoxib; oral

1.3

9.7

1540

13533

XCK10

NOMESCO Finland

Photography of fundus of eye

1.5

9.7

299

2010

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.6

9.7

269

1762

D12

ICD-10 Finland

Benign neoplasm of colon, rectum, anus and anal canal

5.1

9.7

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.5

9.6

333

2293

R35

ICD-10 Finland

Polyuria

1.7

9.6

197

1189

R50.9

ICD-10 Finland

Fever, unspecified

1.5

9.6

365

2568

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.6

9.6

231

1458

RD210

NOMESCO Finland

3.0

9.6

173

M01AB55

ATC

diclofenac, combinations; oral

1.7

9.6

197

1192

127

Kela drug reimbursment

Transplant complication

3.0

9.5

174

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.3

9.5

823

6673

C07AA05

ATC

propranolol; systemic

1.4

9.5

442

3237

D02

ICPC

Abdominal pain epigastric

1.9

9.5

146

805

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

1.9

9.5

142

775

A11

ICPC

Chest pain NOS

1.6

9.5

230

1457

J01FA10

ATC

azithromycin; systemic

1.3

9.5

1394

12123

SDA03

NOMESCO Finland

Demanding parodonthologic therapy

1.3

9.4

878

7188

I84.1

ICD-10 Finland

Internal hemorrhoids with other complications

2.4

9.4

343

Z09.8

ICD-10 Finland

Follow-up examination after other treatment for other conditions

2.3

9.4

392

3AC01

NOMESCO Finland

3.4

9.4

132

K50.8

ICD-10 Finland

Other Crohn disease

3.4

9.3

127

K23.8*B37.8

ICD-10 Finland

Esophagitis caused by candidiasis

5.6

9.3

C18.61

ICD-10 Finland

Malignant tumor of the colon descending invasive carcinoma

8.0

9.3

R52.9

ICD-10 Finland

Pain, unspecified

1.6

9.3

217

1361

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.9

9.3

138

752

SPAT1312

SPAT

General health counselling

1.3

9.2

846

6909

NF1AA

NOMESCO Finland

Hip X-ray examination

1.6

9.2

258

1691

C10AX09

ATC

ezetimibe; oral

1.5

9.2

335

2334

-50

ICPC

Medication/prescr/renewal

1.9

9.2

134

726

C18.79

ICD-10 Finland

Malignant tumor of the sigmoid or other unspecified histology

5.7

9.2

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

2.0

9.2

115

588

K92.0

ICD-10 Finland

Haematemesis

2.3

9.1

344

SPAT1211

SPAT

Application of soft bandage

1.6

9.1

254

1664

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.3

9.1

622

4862

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.5

9.1

378

2707

JFB46

NOMESCO Finland

Resection of sigmoid colon

3.1

9.1

157

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.5

9.1

335

2341

R06AX27

ATC

desloratadine; oral

1.4

9.1

556

4268

SPAT1255

SPAT

Intravenous administration of medicine

1.7

9.1

195

1194

SPAT1153

SPAT

Removal of sutures

1.3

9.1

961

8004

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.6

9.0

216

1364

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.1

9.0

103

508

-45

ICPC

Observ/health educat/advice/diet

2.1

9.0

440

R01BA52

ATC

pseudoephedrine, combinations; oral

1.3

9.0

775

6273

K42.9

ICD-10 Finland

Umbilical hernia without obstruction or gangrene

1.8

8.9

139

768

N03AX09

ATC

lamotrigine; oral

2.2

8.9

420

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.3

8.9

1103

9367

SPAT1262

SPAT

Handing over of treatment supplies

1.4

8.8

547

4211

K22.7

ICD-10 Finland

Barrett oesophagus

2.9

8.8

184

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.1

8.7

452

TKC20

NOMESCO Finland

Catheterisation of bladder

1.6

8.7

221

1416

B01AB10

ATC

tinzaparin; parenteral

1.6

8.7

197

1224

SPAT1081

SPAT

Cardiorespiratory global assessment

1.7

8.7

180

1087

U05

ICPC

Urination problems other

1.8

8.7

143

806

E000001

ATC

1.4

8.7

494

3745

D07AB02

ATC

hydrocortisone butyrate; topical

1.3

8.7

705

5653

R95

ICPC

Chron obstructive pulmonary disease

2.2

8.7

420

L03

ICPC

Low back symptom/complaint

1.3

8.7

603

4723

D07AC01

ATC

betamethasone; topical

1.3

8.7

918

7632

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

2.6

8.7

233

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.7

8.6

169

1006

D18

ICPC

Change in faeces/bowel movements

2.4

8.6

296

R04.0

ICD-10 Finland

Epistaxis

1.6

8.6

215

1372

M01AE02

ATC

naproxen; oral, rectal

1.3

8.6

1436

12625

C09CA06

ATC

candesartan; oral

1.3

8.6

567

4406

J01FA09

ATC

clarithromycin; systemic

1.3

8.6

745

6032

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.7

8.5

182

1114

S29

ICPC

Skin symptom/complaint other

1.4

8.5

461

3465

XF402

NOMESCO Finland

ECG with work load test

1.5

8.5

339

2408

J01MA14

ATC

moxifloxacin; systemic

1.6

8.5

244

1610

K78

ICPC

Atrial fibrillation/flutter

1.5

8.5

257

1720

M03BC51

ATC

orphenadrine, combinations; systemic

1.3

8.4

670

5350

K31.7

ICD-10 Finland

Polyp of stomach and duodenum

5.6

8.4

-34

ICPC

Blood test

2.1

8.4

434

K50.1

ICD-10 Finland

Crohn disease of large intestine

3.6

8.4

101

D25

ICPC

Abdominal distension

2.8

8.4

178

K30

ICD-10 Finland

Functional dyspepsia

1.5

8.4

265

1789

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

1.9

8.4

113

596

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

2.3

8.3

320

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.4

8.3

437

3268

N19

ICD-10 Finland

Unspecified kidney failure

2.0

8.3

100

506

TK810

NOMESCO Finland

Hemofiltration

4.1

8.3

A99

ICPC

Disease/condition unspecnature/site

1.6

8.2

223

1452

M01AX17

ATC

nimesulide; oral

1.3

8.2

685

5505

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

2.2

8.2

344

SPAT1260

SPAT

Consultation of another employee

1.4

8.2

499

3823

C02AC05

ATC

moxonidine; oral

1.8

8.2

142

815

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

1.7

8.2

153

902

A11CC03

ATC

alfacalcidol; systemic

2.3

8.2

325

M03BX02

ATC

tizanidine; oral

1.2

8.2

1582

14114

R03AC12

ATC

salmeterol; inhalant

1.8

8.2

127

704

X58

ICD-10 Finland

Exposure to other specified factors

1.5

8.1

316

2229

S21

ICPC

Skin texture symptom/complaint

1.4

8.1

338

2418

JFB44

NOMESCO Finland

Laparoscopic left hemicolectomy

5.4

8.1

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.5

8.1

288

1998

D07AD01

ATC

clobetasol; topical

1.4

8.1

399

2946

J37.0

ICD-10 Finland

Chronic laryngitis

2.1

8.1

455

R01AD05

ATC

budesonide; nasal

1.6

8.1

187

1168

SPAT1281

SPAT

Other administrative function

1.6

8.1

209

1347

R20.2

ICD-10 Finland

Paraesthesia of skin

1.7

8.1

155

919

D75

ICPC

Malignant neoplasm colon/rectum

3.5

8.1

105

R03BA05

ATC

fluticasone; inhalant

1.4

8.1

427

3196

J01EA01

ATC

trimethoprim; systemic

1.3

8.0

607

4809

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

2.4

8.0

292

XF600

NOMESCO Finland

Bloodpressure measurement

1.7

8.0

175

1076

JF2BD

NOMESCO Finland

Extensive colon CT

3.9

8.0

JFA85

NOMESCO Finland

Endoscopic mucosal or submucosal resection in colon

10.0

8.0

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.7

8.0

172

1056

A10AE05

ATC

insulin detemir; parenteral

1.7

8.0

153

907

A10BB12

ATC

glimepiride; oral

1.6

8.0

225

1479

M03BC01

ATC

orphenadrine (citrate); systemic

1.3

8.0

522

4045

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.3

8.0

818

6759

C08CA02

ATC

felodipine; oral

1.5

8.0

293

2046

SCA01

NOMESCO Finland

Simple analysis and advice of nutrition with regard to dentistry

1.3

8.0

573

4508

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.7

7.9

152

900

A02BD03

ATC

lansoprazole, amoxicillin and metronidazole; systemic

1.6

7.9

206

1331

K51.8

ICD-10 Finland

Other ulcerative colitis

3.1

7.9

134

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

7.9

1043

8893

K03.64

ICD-10 Finland

Dental calculus supragingival

1.3

7.9

597

4730

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.7

7.9

153

910

UJF34

NOMESCO Finland

Left colonoscopy

3.5

7.8

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

3.0

7.8

146

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.9

7.8

107

568

D19

ICPC

Teeth/gum symptom/complaint

1.3

7.8

578

4561

R22.0

ICD-10 Finland

Localized swelling, mass and lump, head

2.0

7.8

448

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

1.7

7.8

165

1008

G04CA01

ATC

alfuzosin; oral

1.4

7.8

386

2854

KMAK

NOMESCO Finland

1.2

7.8

1230

10702

I85.9

ICD-10 Finland

Oesophageal varices without bleeding

3.4

7.8

108

JJC00

NOMESCO Finland

Allogenic transplantation of liver

10.8

7.8

-62

ICPC

Administrative procedure

2.1

7.8

428

D16

ICPC

Rectal bleeding

2.3

7.7

305

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.7

7.7

159

964

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

3.9

7.7

J05AB11

ATC

valaciclovir; oral

1.4

7.7

319

2279

ZXA10

NOMESCO Finland

Bilateral

1.3

7.7

514

3994

JFA32

NOMESCO Finland

Other endoscopic haemostatic procedure in small intestine

45.1

7.7

N06AX16

ATC

venlafaxine; oral

1.5

7.7

277

1928

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.6

7.7

194

1245

D35.0

ICD-10 Finland

Benign neoplasm: Adrenal gland

2.6

7.6

196

R55

ICD-10 Finland

Syncope and collapse

1.5

7.6

297

2100

A03FA01

ATC

metoclopramide; systemic, rectal

1.3

7.6

538

4220

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.6

7.6

179

1128

A10BK03

ATC

empagliflozin; oral

1.6

7.6

196

1261

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.5

7.6

274

1905

C07AB02

ATC

metoprolol; systemic

1.3

7.6

612

4893

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.5

7.5

235

1583

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.4

7.5

353

2582

BC1AD

NOMESCO Finland

CT of adrenal glands

3.8

7.5

K64.2

ICD-10 Finland

Third degree haemorrhoids

3.8

7.5

N17.9

ICD-10 Finland

Acute renal failure, unspecified

1.8

7.5

116

643

J01FA15

ATC

telithromycin; oral

1.5

7.5

236

1592

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

4.3

7.5

R06AX22

ATC

ebastine; oral

1.4

7.5

372

2751

L02

ICPC

Back symptom/complaint

1.6

7.5

198

1281

R31

ICD-10 Finland

Unspecified haematuria

1.4

7.5

320

2304

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

3.5

7.5

Z94.4

ICD-10 Finland

Liver transplant status

7.1

7.5

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.4

7.5

449

3434

C07AG02

ATC

carvedilol; oral

1.6

7.4

184

1174

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.3

7.4

1009

8623

C19

ICD-10 Finland

Malignant neoplasm of rectosigmoid junction

4.2

7.4

R03AK08

ATC

formoterol and beclometasone; inhalant

2.0

7.4

494

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

2.8

7.4

158

L04AA06

ATC

mycophenolic acid; systemic

2.5

7.4

206

N06AA09

ATC

amitriptyline; systemic

1.5

7.3

257

1779

M01AE01

ATC

ibuprofen; systemic, rectal

1.3

7.3

2495

23587

C184, 8211, 2

ICD-O-3

+∞

7.3

WYA10

NOMESCO Finland

First aid or other corresponding healthcare contact

1.6

7.3

171

1077

R07.3

ICD-10 Finland

Other chest pain

1.5

7.3

252

1738

A03

ICPC

Fever

1.4

7.3

298

2126

JDA05

NOMESCO Finland

Endoscopic polypectomy in stomach or pylorus

4.9

7.3

X59

ICD-10 Finland

Exposure to unspecified factor

1.4

7.3

447

3428

R33

ICD-10 Finland

Retention of urine

1.5

7.3

239

1631

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

2.3

7.3

296

A03CA02

ATC

clidinium and psycholeptics; oral

1.6

7.2

169

1062

SAB01

NOMESCO Finland

Restricted oral and dental health check by dental hygienist or dental assistant

1.6

7.2

174

1103

H25.1

ICD-10 Finland

Senile nuclear cataract

1.3

7.2

766

6346

SPAT1127

SPAT

Enema

3.4

7.2

R05

ICPC

Cough

1.3

7.2

558

4433

K57.2

ICD-10 Finland

Diverticular disease of large intestine with perforation and abscess

2.3

7.2

278

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

2.3

7.2

278

A02BX02

ATC

sucralfate; oral

1.8

7.2

117

663

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

1.7

7.1

131

768

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.0

7.1

444

M02AA07

ATC

piroxicam; topical

1.2

7.1

1008

8641

XW000

NOMESCO Finland

Bone marrow biopsy

1.8

7.1

120

683

JAH01

NOMESCO Finland

Laparoscopy

1.9

7.1

101

544

L04AD01

ATC

ciclosporin; systemic

2.5

7.1

214

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.3

7.1

636

5154

JF1CG

NOMESCO Finland

Extensive MRI of small bowel

5.0

7.1

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

3.0

7.1

128

XG466

NOMESCO Finland

Sleep oxymetry

1.9

7.1

532

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

2.5

7.1

216

A12BA01

ATC

potassium chloride; oral

1.7

7.1

130

762

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.2

7.0

1380

12254

I20.09

ICD-10 Finland

Unstable angina

1.6

7.0

173

1101

WVA20

NOMESCO Finland

Medicine administration

2.4

7.0

244

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.5

7.0

256

1784

M01AC06

ATC

meloxicam; systemic, rectal

1.2

7.0

957

8166

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

2.2

7.0

308

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

2.0

7.0

403

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.5

7.0

203

1347

C20.99

ICD-10 Finland

Malignant tumor of the rectum other or unspecified histology

4.0

7.0

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.8

6.9

111

624

M54

ICD-10 Finland

Dorsalgia

1.5

6.9

252

1758

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.0

6.9

462

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.0

6.9

462

A01AB09

ATC

miconazole; local oral

1.5

6.9

219

1484

A10BD07

ATC

metformin and sitagliptin; systemic

1.7

6.9

122

709

Z53.0

ICD-10 Finland

Procedure not carried out because of contraindication

5.8

6.9

N01

ICPC

Headache

1.6

6.9

181

1172

A08

ICPC

Swelling

1.8

6.9

118

679

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.5

6.9

227

1550

JGB00

NOMESCO Finland

Partial proctectomy and colorectal or coloanal anastomosis

3.6

6.9

H04.10

ICD-10 Finland

Dry eye syndrome

1.5

6.9

234

1608

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.4

6.8

287

2058

N40

ICD-10 Finland

Hyperplasia of prostate

1.3

6.8

732

6065

B81

ICPC

Anaemia vit B12/folate deficiency

1.8

6.8

114

651

S04

ICPC

Lump/swelling localized

1.5

6.8

219

1486

A04.8

ICD-10 Finland

Other specified bacterial intestinal infections

2.5

6.8

190

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.1

6.8

367

A02BD07

ATC

lansoprazole, amoxicillin and clarithromycin; systemic

1.7

6.8

145

892

L01

ICPC

Neck symptom/complaint

1.4

6.8

324

2383

K60.1

ICD-10 Finland

Chronic anal fissure

2.4

6.8

227

J01

ICD-10 Finland

Acute sinusitis

1.9

6.8

517

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

1.3

6.8

561

4495

C18.99

ICD-10 Finland

Malignant tumor in unspecified location in the colon other or unspecified histology

5.6

6.7

SDA04

NOMESCO Finland

Very demanding parodonthologic therapy

1.3

6.7

539

4296

L14

ICPC

Leg/thigh symptom/complaint

1.5

6.7

193

1278

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.9

6.7

491

J31.0

ICD-10 Finland

Chronic rhinitis

1.6

6.7

179

1165

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.3

6.7

632

5151

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

1.8

6.7

109

619

H25.8

ICD-10 Finland

Other senile cataract

1.4

6.6

324

2394

GD1LA

NOMESCO Finland

2.5

6.6

195

130

Kela drug reimbursment

Malignant tumour

1.5

6.6

248

1744

A13

ICPC

Concern/fear medical treatment

2.5

6.5

196

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

1.5

6.5

194

1296

K02.0

ICD-10 Finland

Caries limited to enamel

1.5

6.5

240

1679

-48

ICPC

Clarification/discussion RFE/demand

2.3

6.5

247

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

1.7

6.5

127

761

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

2.0

6.5

384

K83.0

ICD-10 Finland

Cholangitis

2.6

6.5

172

J46

ICD-10 Finland

Status asthmaticus

2.1

6.5

326

Z49.1

ICD-10 Finland

Extracorporeal dialysis

2.5

6.5

191

D37.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Rectum

3.0

6.5

114

R05FA02

ATC

opium derivatives and expectorants; systemic

1.2

6.5

1051

9129

V03AE03

ATC

lanthanum carbonate; oral

5.3

6.4

L05

ICPC

Flank/axilla symptom/complaint

1.6

6.4

145

905

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.4

6.4

253

1791

SPAT1058

SPAT

PEF monitoring instruction

1.5

6.4

219

1504

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

1.8

6.4

105

595

K03.66

ICD-10 Finland

Tooth plaque

1.6

6.4

156

992

8211/2-C18.2

ICD-O-3

Tubular adenocarcinoma in situ of ascending colon

70.0

6.4

C189, 8211, 2

ICD-O-3

70.0

6.4

R5140

NOMESCO Finland

Monitoring the use of the aid

1.4

6.4

276

1988

M54.2

ICD-10 Finland

Cervicalgia

1.6

6.4

165

1065

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.6

6.4

171

1111

A10BK01

ATC

dapagliflozin; oral

1.7

6.4

112

650

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.5

6.4

210

1436

K57.9

ICD-10 Finland

Diverticular disease of intestine, part unspecified, without perforation or abscess

2.1

6.4

308

SPAT1139

SPAT

Nutrition survey

1.9

6.4

493

P03

ICPC

Feeling depressed

1.6

6.4

144

899

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.4

6.4

278

2008

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.4

6.4

252

1787

A05AA02

ATC

ursodeoxycholic acid; oral

2.8

6.4

131

R19.4

ICD-10 Finland

Change in bowel habit

2.1

6.3

332

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

1.9

6.3

496

G50.0

ICD-10 Finland

Trigeminal neuralgia

2.6

6.3

169

K29.9

ICD-10 Finland

Gastroduodenitis, unspecified

3.0

6.3

116

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

2.3

6.3

245

L15

ICPC

Knee symptom/complaint

1.3

6.3

534

4291

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.3

6.3

592

4820

JFB50

NOMESCO Finland

Other resection of colon

5.5

6.3

B01AC04

ATC

clopidogrel; oral

1.3

6.3

495

3935

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.5

6.3

231

1615

D07AB08

ATC

desonide; topical

1.4

6.3

241

1703

WX882

NOMESCO Finland

High dependency care

2.0

6.3

376

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.6

6.2

171

1123

N18.8

ICD-10 Finland

Other chronic renal failure

1.9

6.2

462

L86

ICPC

Back syndrome with radiating pain

1.6

6.2

136

843

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.4

6.2

281

2044

G04CB01

ATC

finasteride; oral (testosterone-5-alpha reductase inhibitors)

1.4

6.2

352

2667

N18.0

ICD-10 Finland

End-stage renal disease

2.6

6.2

158

ND1AA

NOMESCO Finland

Wrist X-ray examination

1.6

6.2

137

851

Z49.0

ICD-10 Finland

Preparatory care for dialysis

2.8

6.2

128

H53.1

ICD-10 Finland

Subjective visual disturbances

1.6

6.2

156

1003

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.6

6.1

156

1006

J01DA08

ATC

[U] cefaclor; oral

1.5

6.1

186

1252

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

1.7

6.1

111

653

T82

ICPC

Obesity

2.0

6.1

363

JN1AD

NOMESCO Finland

CT examination of upper part of abdomen

4.7

6.1

N06AX26

ATC

vortioxetine; oral

1.8

6.1

553

KF8AE

NOMESCO Finland

Ultrasound examination of scrotum

2.1

6.1

290

PE1AT

NOMESCO Finland

Femoral artery PTA

2.6

6.0

161

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

2.1

6.0

316

L82

ICD-10 Finland

Seborrhoeic keratosis

1.3

6.0

421

3291

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3022145) Colonoscopy Study observation

1512

3482

6.68

307.65

1.6

1.3

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

2236

14625

2.35

133.44

6.9

5.0

g/l

34.9

0.22

2136

13567

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

872

3788

2.71

129.31

4.6

4.1

ug/l

8.8

23.8

2.92

748

3126

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1502

8526

2.29

122.69

3.0

2.2

mg/l

3.5

3.0

8.95

1347

7246

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2463

17250

2.30

118.33

7.2

6.5

umol/l

11.3

12.0

2.04

2374

16397

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1912

12379

2.13

108.04

4.0

2.8

ug/l

133.3

154.9

2.77

1804

11278

(3048689) Calprotectin [Mass/mass] in Stool

731

3156

2.64

107.81

2.7

2.1

ug/g

151.2

154.4

0.07

618

2443

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

3132

24866

2.75

106.23

10.5

7.9

u/l

80.0

79.9

0.05

3013

23370

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2230

15469

2.12

103.06

8.0

6.2

mmol/l

1.2

1.59

2083

13941

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2081

14115

2.09

101.50

2.4

2.1

pmol/l

92.4

93.6

0.54

1202

7348

(40768797) Stomach Pathology biopsy report

914

4537

2.35

98.74

1.3

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

2490

18235

2.13

96.72

10.3

9.1

e9/l

4.3

4.2

1.26

2216

15826

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1639

10320

2.06

96.23

3.1

2.6

u/l

60.5

58.9

0.35

1529

9485

(40768804) Tissue Pathology biopsy report

1911

12774

2.03

94.45

2.5

2.2

—

(3001604) Monocytes [#/volume] in Blood

2209

15593

2.04

93.22

7.1

5.7

e9/l

0.6

0.28

1938

13311

(3006315) Basophils [#/volume] in Blood

2217

15679

2.04

92.95

7.1

5.7

e9/l

0.0

0.18

1946

13400

(3019198) Lymphocytes [#/volume] in Blood

2239

15962

2.03

90.88

7.1

5.8

e9/l

1.8

1.9

2.38

1979

13865

(3013115) Eosinophils [#/volume] in Blood

2260

16191

2.03

90.14

7.4

5.9

e9/l

0.2

0.18

1998

14031

(3022948) Iron [Moles/volume] in Serum or Plasma

990

5374

2.15

84.14

3.5

2.6

umol/l

11.5

12.6

4.83

931

4984

(40758558) Short blood count panel - Blood

1320

7996

2.02

83.23

7.5

6.8

—

(3031040) Bacteria [#/volume] in Urine by Automated count

2711

21032

2.10

83.05

6.2

4.8

e6/l

147.7

1681.2

2.79

321

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2316

17008

1.98

82.68

9.5

7.1

mmol/l

1.2

2.58

2084

14300

(3044640) Blood type and Crossmatch panel - Blood

1591

10348

1.95

81.05

3.1

2.6

—

(3013707) Erythrocyte sedimentation rate by Westergren method

2901

23239

2.18

79.44

5.7

4.2

mm/h

14.9

13.5

4.70

2725

21341

(3004789) Transferrin [Mass/volume] in Serum or Plasma

926

5000

2.14

79.09

3.4

2.6

g/l

2.3

2.66

875

4633

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

886

4713

2.16

78.58

3.5

2.6

20.1

22.4

4.99

786

3999

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1299

7978

1.97

77.50

3.1

2.5

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

1229

7427

1.98

76.68

5.3

3.7

—

(3033658) Prothrombin time (PT) actual/Normal

1328

8299

1.94

74.64

5.9

4.1

86.6

86.5

0.07

1298

8112

(3014576) Chloride [Moles/volume] in Serum or Plasma

845

4535

2.12

72.51

8.1

6.7

mmol/l

104.3

104.4

0.30

835

4424

(3013826) Glucose [Moles/volume] in Serum or Plasma

2522

19516

1.93

71.66

6.7

4.9

mmol/l

7.0

6.8

4.37

2396

18388

(40761535) Cells panel - Urine sediment

598

2864

2.30

67.71

4.9

3.5

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1595

10837

1.83

67.12

3.5

3.1

ng/l

1747.9

1534.2

0.64

1416

9406

(3019309) Folate [Moles/volume] in Red Blood Cells

1115

6770

1.93

66.80

1.9

1.8

nmol/l

1194.9

1174.9

0.27

888

5030

(3007164) IgA [Mass/volume] in Serum or Plasma

919

5258

2.00

65.30

1.6

1.5

g/l

2.7

2.6

0.16

534

3076

(3000991) Gas panel - Venous blood

601

2943

2.25

64.27

7.9

8.2

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2029

15005

1.79

62.71

4.9

4.2

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

983

5852

1.93

61.65

1.3

1.2

u/ml

1.0

1.7

2.93

223

1464

(3032080) INR in Blood by Coagulation assay

1964

14438

1.77

61.46

12.4

10.4

inr

1.4

1.3

1.10

363

4014

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

3434

30435

2.94

61.27

25.4

16.3

mg/l

26.3

25.9

0.31

2988

24642

(3015377) Calcium [Moles/volume] in Serum or Plasma

1622

11308

1.78

60.75

3.9

3.5

mmol/l

2.3

2.4

0.26

1412

9739

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2776

22706

1.91

60.02

4.5

3.9

pmol/l

15.1

15.0

1.42

2566

20305

(3037467) Urinalysis macro (dipstick) panel - Urine

2684

21751

1.87

59.32

5.9

4.5

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

970

5828

1.90

58.71

3.3

2.9

e6/l

1.6

1.1

0.92

612

3394

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2403

18945

1.77

56.88

4.4

3.2

u/l

60.0

55.3

1.35

2244

17332

(3007853) Bacteria identified in Skin by Aerobe culture

697

3782

2.04

56.52

2.1

1.8

—

(3027945) Reticulocytes/100 erythrocytes in Blood

756

4231

1.99

56.16

2.7

2.4

1.8

0.41

673

3716

(3019150) Specific gravity of Urine by Refractometry

1073

6741

1.84

55.96

5.9

4.3

kg/l

1.0

0.13

167

1016

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1788

13046

1.72

55.19

5.0

3.9

ng/l

42.2

86.6

0.75

1412

9795

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

531

2622

2.20

55.04

5.0

3.9

ng/l

106.0

96.5

1.25

482

2241

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

753

4237

1.98

54.95

7.2

7.0

kpa

5.1

0.67

726

4043

(3014111) Lactate [Moles/volume] in Serum or Plasma

604

3139

2.11

54.89

6.4

6.8

mmol/l

1.4

0.41

589

3029

(3003396) Base excess in Arterial blood by calculation

752

4234

1.98

54.75

7.2

7.0

mmol/l

1.0

1.1

0.09

606

3302

(3026493) Urate [Moles/volume] in Serum or Plasma

1320

8869

1.76

54.60

3.6

2.9

umol/l

3448.8

5822.9

1.39

1175

7567

(3027801) Oxygen [Partial pressure] in Arterial blood

751

4237

1.97

54.31

7.2

7.0

kpa

11.5

12.1

2.77

722

4044

(42870588) Differential panel, method unspecified - Blood

1563

11060

1.72

53.39

6.9

5.8

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

3191

27728

2.14

53.29

5.8

4.7

mu/l

2.0

2.1

0.49

2966

24930

(3020891) Body temperature

346

1439

2.55

52.99

6.3

4.5

—

(3035350) Ketones [Presence] in Urine by Test strip

2008

15235

1.70

52.70

5.1

3.8

estimate

0.0

0.50

215

2862

(3023368) Bacteria identified in Blood by Culture

1418

9828

1.72

51.81

5.0

4.4

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

749

4292

1.94

51.44

12.4

7.4

—

(3009261) Glucose [Presence] in Urine by Test strip

2025

15461

1.69

51.34

5.2

3.8

estimate

0.0

0.35

221

2792

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

603

3216

2.05

50.80

2.7

2.2

g/l

0.2

0.64

569

2986

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1003

6335

1.80

50.49

3.4

3.1

mmol/l

2.5

0.34

884

5565

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

502

2509

2.16

50.19

1.9

1.6

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

388

1745

2.37

50.01

1.8

1.7

g/l

1.6

0.08

350

1493

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

565

2969

2.07

49.47

3.0

2.4

u/l

75.0

39.8

0.47

498

2534

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1473

10422

1.69

49.14

2.6

2.2

u/l

177.1

224.1

1.61

1394

9746

(40761511) CBC panel - Blood by Automated count

3454

31272

2.72

48.32

23.7

15.6

—

(3021601) Nitrite [Presence] in Urine by Test strip

1986

15270

1.65

47.39

6.7

5.1

estimate

0.0

0.50

227

2898

(3021447) Carbon dioxide [Partial pressure] in Venous blood

607

3322

1.99

47.30

5.2

3.7

kpa

5.8

0.36

587

3224

(3020779) Urea [Moles/volume] in Serum or Plasma

603

3293

1.99

47.28

10.7

7.3

mmol/l

10.8

10.6

0.43

577

3127

(3002032) Base excess in Venous blood by calculation

605

3316

1.99

46.92

5.2

3.7

mmol/l

1.8

2.0

0.71

500

2705

(3018010) Neutrophils/100 leukocytes in Blood

1935

14810

1.65

46.76

7.2

5.9

59.0

58.1

2.87

1795

13752

(3019069) Monocytes/100 leukocytes in Blood

1930

14764

1.65

46.72

7.7

6.3

8.8

8.9

0.44

1806

13732

(3006504) Eosinophils/100 leukocytes in Blood

1922

14698

1.64

46.50

7.3

6.0

2.9

0.01

1793

13620

(3016502) Oxygen saturation in Arterial blood

672

3830

1.92

46.42

7.6

7.3

95.5

0.03

657

3682

(3030467) Casts [#/volume] in Urine by Automated count

1352

9468

1.68

46.12

4.1

3.3

e6/l

0.4

0.5

0.53

1066

7190

(3024354) Oxygen [Partial pressure] in Venous blood

518

2715

2.06

45.41

3.5

3.1

kpa

4.6

4.5

0.25

495

2629

(3002030) Lymphocytes/100 leukocytes in Blood

1952

15040

1.63

45.38

7.5

6.2

25.4

26.7

5.41

1806

13900

(36304419) Bacteria [Presence] in Urine

1304

9083

1.68

45.18

4.1

3.2

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

391

1842

2.26

45.04

2.6

2.5

—

(3018095) Leukocytes [#/volume] in Urine

1599

11745

1.64

44.90

4.9

3.9

e6/l

65.3

108.4

2.17

1175

8536

(3002173) Hemoglobin [Mass/volume] in Arterial blood

624

3510

1.94

44.68

7.9

7.8

g/l

120.2

120.7

0.24

609

3377

(3021960) Folate [Moles/volume] in Serum or Plasma

1216

8354

1.68

44.18

1.7

1.6

nmol/l

20.8

20.3

0.40

1089

7058

(3003458) Phosphate [Moles/volume] in Serum or Plasma

762

4608

1.82

43.39

8.8

5.9

mmol/l

1.0

0.37

723

4272

(3022096) Basophils/100 leukocytes in Blood

1858

14314

1.60

41.85

7.4

6.1

0.7

0.83

1736

13273

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1018

6755

1.70

41.67

1.9

1.7

mg/l

1.3

1.4

0.71

824

5278

(3018418) pH of Serum or Plasma

1405

10136

1.62

41.45

5.8

4.2

7.4

0.49

146

1946

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

629

3629

1.88

41.43

3.9

2.8

umol/l

8.5

9.2

0.34

550

3193

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

704

4217

1.83

41.11

3.8

4.2

u/l

235.6

244.8

1.08

671

3980

(3014765) Yersinia sp identified in Stool by Organism specific culture

224

851

2.74

40.95

1.4

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

225

858

2.73

40.84

1.5

1.2

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

3493

32167

2.72

40.35

29.8

19.2

mmol/l

139.6

139.7

0.99

3449

31378

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1690

12805

1.59

40.28

2.7

2.2

nmol/l

78.2

78.8

0.34

1541

11280

(3023103) Potassium [Moles/volume] in Serum or Plasma

3497

32232

2.74

40.13

29.8

19.4

mmol/l

4.0

0.68

3450

31401

(4010399)

448

2327

2.05

39.97

1.6

1.4

—

(3012516) Albumin [Mass/volume] in Urine

1459

10708

1.60

39.58

3.9

3.3

mg/l

586.8

348.0

0.97

1038

6847

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

577

3285

1.90

39.44

2.9

2.4

ug/l

6.6

7.3

0.37

513

2875

(3012095) Magnesium [Moles/volume] in Serum or Plasma

877

5661

1.72

39.38

3.7

3.2

mmol/l

0.8

0.34

832

5276

(3042936) Bacteria identified in Isolate by Culture

766

4778

1.76

38.78

2.4

2.0

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

218

842

2.69

38.57

1.4

1.2

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

497

2712

1.96

38.51

3.0

2.8

ml/min/173m2

62.7

62.2

0.09

215

1127

(3019060) Gas panel - Arterial blood

463

2474

2.00

38.09

5.4

4.7

—

(3009508) Creatinine [Moles/volume] in Urine

1474

10931

1.58

37.74

3.8

3.2

mmol/l

7.3

7.4

0.29

1278

9081

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

3232

29001

1.95

37.63

8.4

6.4

mmol/mol

41.5

40.6

6.20

3044

26514

(3020630) Protein [Mass/volume] in Serum or Plasma

550

3130

1.89

37.50

2.6

2.7

g/l

65.7

66.2

0.94

494

2841

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3499

32394

2.66

37.27

16.0

11.3

u/l

25.5

26.1

1.10

3426

31095

(3023520) Reticulocytes [#/volume] in Blood

559

3213

1.87

36.91

2.8

2.6

e9/l

70.2

69.5

0.17

433

2452

(3020682) Albumin/Creatinine [Ratio] in Urine

1507

11276

1.57

36.86

4.7

4.0

mg/mmol

14.8

9.8

2.71

1081

7174

(3022217) INR in Platelet poor plasma by Coagulation assay

780

4970

1.72

36.33

38.2

27.3

inr

1.6

1.4

1.55

710

(3018405) Lactate [Moles/volume] in Arterial blood

286

1295

2.31

35.97

5.5

3.6

mmol/l

1.4

0.05

281

1273

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

286

1306

2.29

35.24

2.8

3.0

u/ml

0.3

0.32

160

746

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1340

9885

1.56

34.17

4.0

3.3

u/l

36.8

37.9

0.12

1278

9356

(3004716) Salmonella sp identified in Stool by Organism specific culture

264

1182

2.33

34.05

1.5

1.3

—

(3037522) Nuclear Ab [Titer] in Serum

623

3811

1.76

33.22

1.4

1.3

titre

548.2

509.8

0.20

132

824

(3000494) Fungus identified in Specimen by Culture

619

3786

1.76

33.01

1.7

1.4

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

3486

32441

2.44

32.69

29.7

19.4

umol/l

87.0

81.7

8.96

3486

32430

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

823

5461

1.65

32.42

3.7

3.1

e6/l

2.2

2.0

0.32

466

3053

(3026008) Bacteria identified in Urine by Culture

1353

10089

1.54

32.42

3.9

3.3

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

829

5537

1.64

31.73

2.4

2.0

30.1

30.0

0.18

811

5367

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

327

1648

2.08

31.38

4.8

3.9

mmol/l

23.9

24.2

0.71

297

1474

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

325

1639

2.08

31.12

3.0

2.6

0.7

0.61

319

1566

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

3297

30156

1.90

30.78

6.3

5.0

mmol/l

6.2

6.1

9.26

3087

27098

(3004588) Protein electrophoresis panel - Serum or Plasma

459

2621

1.86

30.59

2.3

2.5

—

(3000850) Epithelial cells [#/volume] in Urine

1025

7264

1.57

30.44

3.2

2.7

e6/l

4.7

4.8

0.07

892

6353

(3002582) Erythrocytes [#/volume] in Urine

1361

10317

1.51

29.41

4.3

3.4

e6/l

67.2

78.5

0.20

1064

8011

(3000570) Elastase.pancreatic [Mass/mass] in Stool

222

983

2.34

29.33

1.4

ug/g

258.5

267.6

0.26

132

584

(3006462) Nitrate [Presence] in Urine

157

4.53

28.95

5.0

3.8

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

361

1944

1.95

28.70

8.1

9.1

mmol/l

24.2

24.3

0.05

330

1818

(3013139) Helicobacter pylori Ag [Presence] in Stool

368

2009

1.92

28.07

1.3

1.2

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

223

1009

2.29

28.01

1.7

1.6

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

3340

30852

1.90

27.69

6.4

5.4

mmol/l

2.5

2.6

13.05

3143

27979

(36660697) Celiac disease serology panel - Serum

385

2149

1.88

27.42

1.2

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

269

1324

2.11

27.41

3.5

3.4

u/ml

1601.8

4092.2

0.49

235

1128

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

3177

28946

1.72

27.23

5.1

4.2

mmol/l

1.4

1.3

7.19

2955

25971

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

840

5814

1.58

27.15

2.2

1.8

—

(4211845)

170

4.24

27.04

4.9

3.7

—

(3000963) Hemoglobin [Mass/volume] in Blood

3529

33317

2.47

26.76

38.8

24.2

g/l

131.9

134.7

20.60

3499

32782

(3007461) Platelets [#/volume] in Blood

3528

33305

2.46

26.73

38.5

24.0

e9/l

242.8

243.1

0.08

3490

32374

(3037121) Protein [Mass/volume] in Urine

246

1182

2.16

26.66

3.0

3.1

g/l

0.3

0.15

126

479

(3024731) MCV [Entitic volume]

3528

33310

2.46

26.63

38.4

23.9

91.6

0.01

3501

32772

(3009445) Proteinase 3 Ab [Units/volume] in Serum

285

1449

2.05

26.62

1.4

1.6

u/ml

6.5

22.8

—

(3026361) Erythrocytes [#/volume] in Blood

3528

33312

2.46

26.59

38.6

24.0

e12/l

4.4

9.27

3475

32257

(3035941) MCH [Entitic mass]

3527

33310

2.44

26.36

38.4

23.9

30.4

30.5

2.44

3501

32770

(3010813) Leukocytes [#/volume] in Blood

3527

33317

2.44

26.23

38.6

24.0

e9/l

7.0

6.8

4.65

3478

32258

(3003327) Ova and parasites identified in Stool by Light microscopy

189

820

2.38

26.14

1.7

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

543

3406

1.70

25.96

1.4

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

405

2341

1.82

25.75

9.2

6.6

mmol/l

24.6

24.5

0.13

384

2178

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

3178

29055

1.69

25.66

21.0

15.6

ml/min/173m2

74.1

75.8

4.41

2749

24141

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

269

1365

2.05

25.24

5.4

4.1

mmol/l

24.7

24.8

0.35

252

1256

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

616

4025

1.64

25.09

2.1

1.8

—

(3044889) 12 lead EKG panel

2593

22696

1.48

25.00

5.4

4.2

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

3246

29889

1.73

24.98

5.6

4.7

mmol/l

1.4

4.00

3047

27054

(3025941) Bacteria identified in Stool by Culture

299

1582

1.97

24.94

1.5

1.3

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

617

4041

1.63

24.88

2.0

1.8

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

283

1479

1.99

24.44

2.4

g/l

3.9

3.8

0.12

193

1060

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

222

1061

2.16

24.37

1.4

1.3

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

269

1383

2.02

24.33

2.4

2.5

g/l

3.2

3.1

0.52

196

1084

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

283

1482

1.99

24.30

2.4

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

283

1483

1.98

24.25

2.4

g/l

7.5

7.4

0.19

203

1103

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

3262

30140

1.73

23.97

5.7

4.8

mmol/l

4.4

4.5

10.57

3071

27494

(3028026) IgM [Mass/volume] in Serum or Plasma

329

1839

1.87

23.22

2.0

1.9

g/l

1.2

1.4

0.73

302

1656

(3029937) Albumin [Presence] in Urine by Test strip

1112

8396

1.47

23.17

6.1

4.2

estimate

0.0

0.61

214

2745

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

377

2203

1.79

23.02

1.9

1.7

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

445

2727

1.72

23.02

1.8

1.5

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

245

1244

2.04

22.92

2.6

2.2

ug/l

688.2

661.8

0.02

240

1176

(3009542) Hematocrit [Volume Fraction] of Blood

2943

26601

1.53

22.84

26.9

17.7

38.0

39.2

7.02

1908

17315

(3005719) IgG [Mass/volume] in Serum or Plasma

392

2328

1.77

22.64

2.8

g/l

10.5

10.6

0.06

362

2113

(3026782) Osmolality of Urine

928

6797

1.49

22.43

3.5

2.8

mosm/kgh2o

556.1

552.7

0.19

776

5771

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

208

3.56

21.85

1.3

1.1

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1454

11635

1.41

21.71

5.7

4.1

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

244

1263

2.00

21.63

2.5

g/l

0.8

1.1

0.76

205

1088

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

221

1107

2.06

21.45

2.5

2.3

g/l

0.1

0.0

0.51

193

1013

(3034770) Mitochondria Ab [Titer] in Serum

175

800

2.25

21.45

1.3

1.2

titre

1365.0

1102.1

—

(3000492) Spirometry study

431

2677

1.69

21.13

1.7

1.5

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

226

1151

2.03

20.96

2.5

2.3

g/l

37.0

37.5

0.66

187

988

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

169

3.78

20.61

1.2

1.3

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

207

1028

2.07

20.56

2.5

2.4

g/l

0.0

0.45

180

939

(3007566) Smooth muscle Ab [Titer] in Serum

171

793

2.21

20.25

1.4

1.2

titre

129.1

93.3

0.28

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1862

15654

1.38

20.24

2.7

2.4

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

167

3.76

20.17

1.2

1.3

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

204

1015

2.07

20.17

2.6

2.4

g/l

0.0

0.00

180

938

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

256

1384

1.91

19.98

2.4

2.5

g/l

10.2

0.03

208

1164

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

163

746

2.24

19.93

1.4

—

(3022313) Gas panel - Capillary blood

287

1612

1.85

19.89

5.2

3.9

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

684

4823

1.51

19.54

1.3

iu/ml

30.8

39.0

1.10

211

1493

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

219

1131

2.00

19.54

1.7

1.5

titre

156.0

259.6

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

185

899

2.11

19.47

1.5

—

(3013512) EKG study

1280

10160

1.40

19.44

5.0

4.3

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

357

2159

1.72

19.24

4.8

3.7

mmol/l

1.3

1.9

1.85

271

1575

(3025468) Yersinia sp identified in Specimen by Organism specific culture

110

430

2.61

19.06

1.5

—

(3003338) MCHC [Mass/volume]

2728

24567

1.43

19.00

35.5

21.4

g/l

330.4

332.1

16.90

2710

24384

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

455

2943

1.62

18.95

2.0

1.7

1.6

1.00

390

2507

(3009343) pH of Capillary blood

366

2238

1.71

18.94

4.9

3.7

7.4

0.34

293

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

234

1251

1.93

18.88

3.0

3.5

mg/l

41.3

62.7

1.04

206

1020

(3034860) Kappa light chains.free [Mass/volume] in Serum

234

1252

1.93

18.84

3.0

3.5

mg/l

54.9

104.6

0.56

205

1017

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

230

1224

1.94

18.81

3.0

3.4

ratio

1.2

2.8

1.52

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

110

433

2.59

18.80

1.5

1.4

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

450

2911

1.62

18.73

1.8

1.5

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

110

434

2.58

18.71

1.5

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

111

440

2.57

18.70

1.5

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

113

453

2.54

18.60

1.9

1.7

g/l

0.6

0.9

2.73

345

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

109

433

2.56

18.29

1.5

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

109

436

2.55

18.04

1.5

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

500

3350

1.57

17.91

1.7

1.6

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

366

2273

1.68

17.85

5.0

3.7

kpa

5.1

0.34

341

2106

(3052851) Hemolysis interference index of Serum or Plasma

196

1008

2.00

17.70

3.7

3.5

—

(4062490)

282

2.91

17.52

1.6

1.4

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

163

786

2.12

17.52

3.7

3.0

nmol/l

0.8

1.10

135

594

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

336

2063

1.69

17.09

1.6

1.5

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

232

1279

1.87

17.05

1.1

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

431

2823

1.60

16.96

2.3

nmol/l

357.9

373.1

0.92

393

2577

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

640

4570

1.48

16.96

1.3

1.2

u/ml

20.8

14.9

0.32

219

1661

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

231

1285

1.85

16.50

3.1

2.6

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

138

642

2.19

16.26

1.4

1.3

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

894

6863

1.40

15.88

5.0

4.0

ng/l

272.3

515.8

0.86

768

5772

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

177

916

1.98

15.72

2.9

2.4

g/l

3.6

0.06

170

864

(3027135) IgG subclass 1 [Mass/volume] in Serum

279

2.80

15.52

1.6

1.4

g/l

6.5

7.1

0.81

196

(3024139) IgG subclass 3 [Mass/volume] in Serum

279

2.80

15.52

1.6

1.4

g/l

0.4

0.00

196

(3028192) IgG subclass 2 [Mass/volume] in Serum

279

2.80

15.52

1.6

1.4

g/l

2.7

3.0

0.71

194

(3021589) Normoblasts [#/volume] in Blood

1629

13808

1.32

14.96

11.3

10.2

e9/l

0.0

1.34

1347

11269

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

134

642

2.13

14.69

9.2

5.0

iu/ml

1811.0

3041.6

0.18

(3015171) Extractable nuclear Ab [Units/volume] in Serum

196

1075

1.87

14.65

1.3

1.2

u/ml

0.8

1.4

0.48

(3044927) Protein electrophoresis panel - Urine

397

2.43

14.39

1.2

—

(40757494) Bilirubin.total [Moles/volume] in Blood

189

3.10

14.14

2.3

umol/l

13.2

30.3

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

167

882

1.94

14.01

1.6

iu/ml

1.1

11.0

0.80

195

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

163

861

1.93

13.67

1.6

1.5

g/l

1.2

0.24

155

813

(3005322) IgE [Units/volume] in Serum or Plasma

265

1621

1.68

13.64

1.4

1.3

u/ml

182.5

230.7

0.55

244

1487

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

145

739

2.00

13.48

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

145

739

2.00

13.48

1.4

1.3

—

(40760888) Immunoglobulin light chains.free panel - Serum

174

950

1.87

13.21

2.8

3.6

—

(1761868) Lipid panel - Serum or Plasma

738

9457

0.73

13.20

3.4

3.2

—

(3042733) HLA Ab [Presence] in Serum

4.23

13.15

5.1

4.9

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

353

2.44

13.09

2.2

1.6

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

177

3.08

13.06

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

177

3.08

13.06

1.5

—

(3010375) cycloSPORINE [Mass/volume] in Blood

137

3.39

12.99

35.3

25.0

ug/l

111.0

116.0

0.24

112

(21494890) Protein electrophoresis panel - 24 hour Urine

410

2.33

12.98

2.3

2.1

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

332

2.47

12.83

2.2

1.6

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

128

636

2.05

12.78

1.2

1.1

—

(4035726)

433

3018

1.49

12.71

1.5

1.4

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

156

833

1.91

12.69

1.6

1.5

g/l

0.3

0.2

0.84

148

789

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

344

2.42

12.37

3.1

2.8

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

108

510

2.15

12.34

1.3

1.2

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

160

876

1.86

12.07

1.6

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

191

1104

1.77

12.06

1.1

u/ml

2.9

1.4

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

129

661

1.99

11.86

1.3

1.2

—

(40768441) Liver Pathology biopsy report

221

2.74

11.81

1.9

1.4

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

103

488

2.14

11.69

1.8

1.4

u/ml

111.2

119.3

0.28

101

(3023183) Ammonium ion [Moles/volume] in Plasma

141

750

1.92

11.63

3.0

2.7

umol/l

39.0

35.0

0.57

122

621

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

216

1307

1.69

11.59

2.3

1.8

u/l

38.3

38.7

0.09

185

1121

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

113

558

2.06

11.51

1.7

1.4

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

466

2.16

11.43

1.3

1.2

u/ml

298.2

294.2

0.04

284

(3036489) Thrombin time

195

1152

1.73

11.42

2.3

2.0

23.2

21.6

1.23

179

1039

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

183

2.87

11.16

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

183

2.87

11.16

1.4

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

136

3.19

11.08

3.2

2.5

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

400

2.23

11.08

1.4

1.3

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

161

909

1.81

11.02

2.5

2.2

89.7

89.1

0.12

152

863

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

129

683

1.92

10.81

1.1

u/ml

7.2

6.3

—

(40760892) CBC W Ordered Manual Differential panel - Blood

808

6442

1.33

10.66

5.6

4.7

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

304

2043

1.53

10.59

9.0

9.6

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

244

1562

1.60

10.51

2.3

1.9

ug/l

1.7

2.5

0.72

226

1370

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

142

3.05

10.34

2.8

2.3

97.1

95.4

0.11

132

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1592

13887

1.26

10.27

5.7

5.4

ug/l

2.8

3.7

0.76

1448

12396

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

3.89

10.11

1.2

1.1

pmol/l

206.3

274.9

1.42

(3002256) Pathology report gross observation

567

4318

1.37

10.09

1.4

1.3

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

246

2.50

10.08

1.4

—

(3019225) pH of Specimen

479

3548

1.40

10.08

5.5

4.6

—

(3024471) HLA-A [Type]

3.62

10.07

1.0

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

444

2.10

10.01

1.4

1.3

nmol/l

0.3

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

417

3018

1.43

10.00

1.7

1.6

—

(3024932) HLA-DR beta [Type]

3.67

9.96

1.1

—

(3049717) Cytology report of Urine Cyto stain

241

1562

1.58

9.86

2.8

2.7

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

474

2.05

9.84

6.5

6.8

mg/l

12.6

12.1

0.60

442

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

148

844

1.79

9.84

2.6

2.4

205.7

202.4

0.18

142

800

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

155

897

1.76

9.80

2.3

ug/min

129.1

102.7

0.40

540

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

244

2.48

9.75

1.4

—

(3051611) Lipemic interference index of Serum or Plasma

338

2.24

9.69

3.9

3.5

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

430

2.10

9.67

1.4

e6/l

93397.4

68932.2

0.16

250

(3023199) Leukocytes [#/volume] in Pleural fluid

478

2.04

9.62

1.4

1.5

e6/l

1981.5

1728.2

0.24

345

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

104

536

1.97

9.47

1.3

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

238

2.46

9.27

1.1

1.2

—

(3020491) Glucose [Moles/volume] in Blood

226

2.50

9.27

1.6

2.0

mmol/l

7.2

6.8

0.53

153

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

138

792

1.77

9.00

3.1

3.4

u/ml

89.2

720.5

1.22

133

723

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

126

704

1.82

8.99

1.4

1.6

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

546

4213

1.35

8.86

4.7

4.8

32.4

32.9

0.57

415

2727

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

158

952

1.69

8.68

1.4

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

341

2.16

8.68

1.2

u/l

52.9

59.1

0.45

232

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

246

2.38

8.65

2.2

2.3

—

(44790047)

382

2.09

8.60

2.0

1.4

—

(44790049)

382

2.09

8.60

2.0

1.4

—

(44790048)

382

2.09

8.60

2.0

1.4

—

(44806118)

382

2.09

8.60

2.0

1.4

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

140

818

1.74

8.60

1.7

1.5

—

(3037756) Immunofixation for Serum or Plasma

140

818

1.74

8.60

1.6

1.7

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

516

1.92

8.43

1.5

—

(40768443) Skin Pathology biopsy report

219

1441

1.55

8.42

1.2

—

(3000475) Leukocytes [#/volume] in Synovial fluid

141

833

1.72

8.34

1.7

1.6

e6/l

12180.2

13620.8

0.19

103

594

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

439

3305

1.37

8.33

3.2

3.0

ng/l

240.0

214.5

0.62

403

3036

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

137

804

1.73

8.30

2.7

1.9

mg/l

14.0

11.9

2.19

125

735

(3024891) Influenza virus A+B Ag [Presence] in Specimen

121

685

1.79

8.30

1.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

381

2.07

8.29

1.2

1.3

—

(3024928) Oxygen saturation in Venous blood

131

760

1.75

8.26

2.8

2.9

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

255

1742

1.50

8.24

1.5

1.4

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

382

2.06

8.23

3.7

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

468

1.95

8.05

1.0

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1285

11159

1.23

8.03

5.0

4.6

21.8

22.0

0.15

694

5799

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

236

2.35

8.02

1.3

1.2

titre

65.0

110.0

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

3.64

8.00

1.0

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

142

851

1.70

7.99

3.7

2.8

mg/l

1.8

1.7

1.21

130

764

(3036603) Volume of Urine

218

2.41

7.99

2.0

1.7

1868.1

1845.5

0.02

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

189

2.51

7.89

1.3

u/l

42.9

20.2

0.64

162

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

121

698

1.76

7.81

1.4

1.3

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

110

617

1.81

7.80

1.7

1.4

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

317

2.13

7.76

1.3

1.2

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

391

2.02

7.75

1.5

1.3

nmol/l

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

496

1.90

7.73

1.7

1.4

—

(3026389) Candida sp identified in Specimen by Organism specific culture

402

1.99

7.54

1.3

1.4

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

3.49

7.53

1.0

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

302

2.14

7.47

2.2

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

302

2.14

7.47

2.2

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

302

2.14

7.47

2.2

1.5

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

296

2.15

7.44

1.1

1.0

u/ml

1.8

2.4

0.38

107

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

165

2.56

7.42

2.3

1.6

u/field

3.8

2.3

0.30

115

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

202

2.39

7.34

1.3

1.2

u/l

99.7

88.2

0.31

176

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

258

1814

1.45

7.23

1.4

1.3

au/ml

36.8

56.3

1.01

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

280

2005

1.43

7.12

2.7

2.4

au/ml

50.2

23.3

0.99

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

503

1.85

7.11

4.3

2.5

u/ml

59.6

3109.0

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

175

2.47

7.08

1.1

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

450

1.89

6.93

3.9

2.1

mg/l

24.2

23.0

0.07

107

(3003434) Protein [Mass/volume] in Pleural fluid

552

1.80

6.90

1.4

1.5

g/l

32.7

32.0

0.22

499

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

128

778

1.67

6.88

1.3

1.2

u/ml

10.5

36.3

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

173

2.44

6.75

1.8

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

476

1.85

6.73

1.5

1.4

—

(3045424) Erythrocytes [Presence] in Urine

559

1.77

6.63

1.6

1.5

—

(3005570) Glucose [Moles/volume] in Urine

324

2.02

6.62

1.6

2.0

—

(3006270) Folate [Moles/volume] in Blood

271

2.12

6.57

1.3

1.2

nmol/l

305.7

354.6

1.19

222

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

128

2.67

6.56

1.3

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

289

2113

1.40

6.54

8.8

7.0

mmol/l

24.8

24.9

0.10

284

2100

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

207

2.24

6.10

1.7

1.6

u/l

5.2

6.5

0.27

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

328

1.97

6.06

1.1

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

331

1.95

5.91

1.4

1.3

e6/l

149836.8

109413.0

0.19

227

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

460

1.80

5.90

1.2

1.1

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

130

827

1.59

5.88

2.1

1.5

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

925

7976

1.21

5.83

3.2

ug/l

0.7

0.8

0.60

701

5633

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

327

1.94

5.77

1.4

1.3

—

(3000093) Morphology [Interpretation] in Blood Narrative

334

1.93

5.77

1.2

1.1

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

100

600

1.69

5.71

1.3

1.2

u/ml

1.6

7.3

—

(3051651) Icteric interference index of Serum or Plasma

194

2.23

5.69

4.1

3.6

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

4.07

5.62

5.1

5.3

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

255

2.05

5.59

1.2

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

205

2.16

5.40

2.3

2.0

e6/l

727.3

648.6

0.19

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

115

727

1.60

5.37

1.3

1.2

u/ml

1.7

3.5

1.76

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

542

1.70

5.36

1.3

1.2

u/ml

11.1

47.5

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

103

635

1.64

5.32

2.1

1.6

—

(3045414) Leukocytes [Presence] in Urine

207

1484

1.42

5.29

2.0

1.9

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

116

738

1.59

5.28

1.3

1.2

u/ml

7.9

7.3

0.04

126

(3017446) Testosterone [Moles/volume] in Serum or Plasma

319

2453

1.33

5.28

2.4

2.1

nmol/l

11.4

12.4

1.43

276

2127

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

546

1.68

5.22

1.7

1.3

—

(21494434) Karyotype in Bone marrow

339

1.87

5.22

1.1

1.2

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

224

1633

1.40

5.21

3.1

3.2

pmol/l

4.4

0.30

198

1415

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

130

853

1.54

5.18

2.0

1.5

—

(3045788) Cell count panel - Pleural fluid

376

1.82

5.18

1.5

—

(3017704) Immunofixation for Urine

211

2.10

5.05

1.5

1.6

—

(3023419) Bacteria identified in Sputum by Culture

476

1.72

5.03

3.0

2.5

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

2.82

4.97

1.2

2.2

192.8

202.4

0.13

(3012441) Differential panel - Pleural fluid

421

1.75

4.86

1.4

1.5

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

223

2.03

4.75

1.2

1.3

u/l

33.9

31.4

0.20

182

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

121

799

1.53

4.72

1.2

1.3

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

842

7323

1.19

4.72

1.8

1.7

pmol/l

21924066.7

28433272.8

0.16

707

5979

(3006922) Hepatitis E virus Ab [Presence] in Serum

177

2.16

4.71

1.1

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

191

1382

1.40

4.67

2.1

1.8

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

3.50

4.61

1.3

ng/l

136.8

94.4

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

543

1.64

4.59

2.2

1.9

pmol/l

179.3

201.7

1.31

507

(4146454)

407

1.73

4.55

2.5

2.7

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

269

1.91

4.53

1.0

u/ml

0.7

1.3

0.57

105

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

314

1.83

4.44

1.1

u/ml

0.2

1.5

2.20

123

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

271

1.89

4.44

1.8

u/l

15.7

1649.8

0.99

(40768806) Pleura Pathology biopsy report

433

1.70

4.43

1.5

1.6

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

719

0.50

4.40

4.9

3.6

mg/l

25.0

29.0

0.29

445

(40768446) Kidney Pathology biopsy report

118

2.38

4.39

2.0

1.6

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

3.72

4.36

1.0

1.1

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

559

1.61

4.34

1.6

1.4

—

(3032773) Endomysium IgG Ab [Titer] in Serum

190

2.06

4.34

1.1

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

4.56

4.30

2.1

2.0

—

(44813793)

165

2.13

4.24

1.1

1.0

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

256

1.89

4.16

1.1

1.0

—

(3003181) Sodium [Moles/volume] in Urine

645

1.55

4.15

1.4

1.3

mmol/l

56.2

62.5

0.96

522

(4094501)

129

889

1.47

4.14

1.1

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

194

2.02

4.12

1.6

1.7

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

481

1.64

4.11

1.3

2.0

ug/l

22.9

24.4

0.10

474

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

499

1.62

4.04

1.9

1.5

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

340

1.75

4.00

1.3

1.2

u/ml

78.6

48.0

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

275

1.83

3.96

1.0

u/ml

2.6

3.4

0.25

124

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

170

2.07

3.95

1.1

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

170

2.07

3.95

1.1

1.0

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

224

2900

0.76

3.94

4.9

4.1

mmol/l

1.2

0.61

200

2549

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

199

1494

1.35

3.93

2.4

1.9

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

100

662

1.52

3.92

1.9

1.5

nmol/l

0.9

0.8

0.91

547

(3002385) Erythrocyte distribution width [Ratio]

2576

24607

1.16

3.92

30.4

20.0

14.2

13.8

22.78

2546

24048

(3021788) Differential panel - Synovial fluid

617

1.54

3.84

1.5

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

498

1.60

3.84

1.5

1.4

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

278

1.81

3.83

1.2

1.1

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

107

2.35

3.82

2.3

2.2

e6/l

4428.7

20004.2

0.48

(3014148) Varicella zoster virus Ab [Titer] in Serum

243

1.86

3.78

1.2

1.1

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

3.19

3.77

12.2

14.2

mmol/l

4.5

5.6

0.93

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

237

1.87

3.73

4.2

5.0

u/ml

140.4

59.0

0.37

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.65

3.72

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

3.67

3.63

1.0

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

2.40

3.55

1.1

—

(3017732) Neutrophils [#/volume] in Blood

260

2063

1.28

3.48

3.0

3.3

e9/l

4.4

4.2

0.67

192

1518

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

401

1.63

3.48

1.3

1.2

u/ml

4.2

5.3

0.35

174

(3028433) Virus identified in Specimen by Culture

112

2.24

3.47

1.4

1.2

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

616

1.51

3.46

1.6

1.3

u/l

72.0

43.3

0.51

533

(3003694) ABO and Rh group [Type] in Blood

891

7970

1.16

3.42

1.3

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

120

2.17

3.38

2.6

2.3

e6/l

1100.3

6712.6

0.45

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

491

1.56

3.37

1.3

1.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

203

1567

1.31

3.36

1.2

iu/ml

108.7

137.2

0.57

529

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

2.32

3.33

1.1

1.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

368

1.64

3.30

2.2

1.7

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

149

2.02

3.25

1.2

1.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

3.03

3.25

1.5

umol/l

69.1

41.4

1.23

(40761536) Microorganisms panel - Urine sediment

210

2662

0.78

3.18

5.7

4.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

130

2.08

3.17

2.2

1.4

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

282

1.71

3.12

2.5

1.5

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

187

1.88

3.10

2.7

2.6

42.9

37.4

—

(3047189) Immunofixation for 24 hour Urine

188

1.87

3.05

2.0

1.8

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

239

1.77

3.05

1.6

1.2

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

409

1.57

3.01

1.4

1.5

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

441

1.55

3.00

1.1

—

(3011985) Renin [Units/volume] in Plasma

449

1.55

3.00

1.3

1.4

mu/l

92.7

60.7

0.27

397

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

147

1.98

2.99

1.2

1.1

iu/ml

10.2

12.9

—

(3008898) HLA-B27 [Presence]

102

721

1.43

2.97

1.0

1.1

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

388

1.58

2.94

3.0

4.2

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

115

2.09

2.88

1.1

1.0

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.93

2.85

1.3

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

183

1429

1.30

2.83

1.4

1.3

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

940

8542

1.13

2.81

1.7

mmol/l

1.4

1.3

1.70

843

7058

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

201

1.80

2.81

1.1

1.5

nmol/l

0.2

0.3

0.38

149

(3004616) Nuclear Ab [Presence] in Serum

369

1.58

2.80

1.3

1.2

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

165

1.89

2.80

1.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

376

3186

1.20

2.79

1.5

1.4

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

663

1.43

2.79

1.4

1.5

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

269

1.68

2.78

2.2

2.0

u/field

3.6

1.8

0.35

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

188

1.82

2.74

2.4

1.6

u/l

5.8

7.0

0.61

165

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

118

2.04

2.71

2.8

1.8

ug/l

54.4

53.9

0.01

113

(3033799) Differential panel - Peritoneal fluid

105

2.10

2.68

2.4

2.0

—

(3020393) Adenovirus Ag [Presence] in Stool

3.76

2.67

1.2

1.0

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

569

1.45

2.67

3.2

3.3

—

(3037556) Urate [Mass/volume] in Serum or Plasma

112

2.06

2.67

1.2

1.4

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

161

1.87

2.66

1.2

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

391

1.54

2.64

1.2

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

465

1.49

2.60

2.4

1.8

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

155

1199

1.31

2.60

2.0

1.7

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

127

1.98

2.60

1.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.90

2.58

3.3

1.9

—

(3020874) Milk IgE Ab [Units/volume] in Serum

2.19

2.57

1.0

1.1

u/ml

0.4

1.5

—

(3044941) Cell count panel - Synovial fluid

550

1.45

2.54

1.5

1.4

—

(3003129) Base excess in Capillary blood by calculation

101

2.09

2.52

1.9

mmol/l

-0.3

0.8

0.34

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

130

1.93

2.45

2.7

2.5

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

2.24

2.44

1.0

1.1

63.3

85.6

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

108

801

1.36

2.43

2.0

2.2

g/l

128.1

128.6

0.05

584

(3009214) Lutropin [Units/volume] in Serum or Plasma

541

1.43

2.38

1.4

1.3

u/l

10.7

10.5

0.03

435

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

2.76

2.37

1.1

1.2

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

2.76

2.37

1.5

1.2

ug/l

52.8

144.3

—

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

6.26

2.37

1.0

1.1

g/l

0.2

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

168

1.79

2.36

2.3

2.4

—

(3022475) Manganese [Moles/volume] in Blood

4.12

2.36

1.1

1.3

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

411

1.49

2.34

1.3

1.2

u/ml

6.1

3.5

0.29

135

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

214

1.69

2.32

1.3

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

214

1.69

2.32

1.3

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

214

1.69

2.32

1.3

1.1

—

(3036670) Protein [Mass/volume] in Synovial fluid

112

1.97

2.30

1.2

g/l

38.1

39.4

0.16

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

185

1.74

2.27

3.5

3.2

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.16

2.24

1.4

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

2.10

2.22

2.9

1.5

ug/l

9.6

9.1

0.25

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

217

1.67

2.21

1.3

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

217

1.67

2.21

1.3

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

217

1.67

2.21

1.3

1.1

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

5.56

2.21

1.0

1.2

—

(3011412) CD3 cells [#/volume] in Blood

288

1.57

2.19

2.2

2.1

e9/l

0.9

1.1

0.78

171

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

2.24

2.17

1.1

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

2.07

2.16

1.4

1.5

ug/l

0.3

0.4

0.53

(3045683) HLA typing for celiac disease panel - Blood or Tissue

129

1.87

2.16

1.0

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

138

1081

1.29

2.16

1.9

1.6

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

196

1.69

2.15

2.1

2.0

ug/min

60.4

286.8

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

123

1.88

2.11

1.1

ng/l

68.3

532.3

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

2.05

2.11

2.2

1.3

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

145

1.80

2.10

1.1

1.2

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

414

1.46

2.08

1.2

1.4

pmol/l

329.3

276.4

0.37

317

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

168

1.73

2.07

6.0

6.4

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

2.91

2.07

1.3

2.0

umol/l

17.1

17.9

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

341

1.50

2.06

1.1

—

(3044007) Cell count panel - Peritoneal fluid

1.98

2.05

2.2

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

139

1.80

2.04

2.7

1.7

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.33

2.04

1.2

1.1

—

(4034850)

130

1019

1.29

2.04

9.5

10.7

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

2.40

2.02

1.3

1.1

68.0

51.3

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.64

2.01

1.0

1.2

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

459

1.42

2.00

1.3

miu/ml

203.6

198.4

0.03

172

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

208

1.64

2.00

1.9

2.1

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

303

1.52

2.00

1.3

u/l

16.7

12.6

0.39

277

(4306422)

385

1.46

1.99

1.3

1.2

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

2.08

1.96

1.0

1.3

49.1

83.2

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

134

1.80

1.95

1.6

1.2

—

(3051593) INR in Capillary blood by Coagulation assay

187

1.66

1.93

5.6

13.4

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.97

1.93

1.0

1.4

—

(3035880) pH of Pleural fluid

226

1.60

1.93

1.3

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

234

1.59

1.92

1.1

1.0

u/ml

0.0

2.4

—

(40757373) Influenza virus identified in Isolate

2.06

1.90

2.3

1.4

—

(3035637) Corticotropin [Mass/volume] in Plasma

390

1.44

1.88

1.3

1.6

—

(3048879) Bone marrow aspiration report

114

1.85

1.87

1.9

1.6

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

374

1.45

1.86

3.0

3.7

61.1

57.3

0.76

227

(3030981) Hyaline casts [#/volume] in Urine by Automated count

220

1849

1.20

1.86

3.5

2.9

e6/l

0.2

0.3

0.70

214

1811

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

3.53

1.83

3.5

6.5

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

3.53

1.83

3.3

1.3

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.50

1.83

1.9

2.2

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

198

1.62

1.83

1.1

u/ml

0.5

2.3

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

4.17

1.82

1.0

u/ml

0.0

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

161

1315

1.23

1.82

2.6

3.7

u/ml

36.4

70.7

2.81

154

1261

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

254

1.54

1.81

1.1

—

(4024509)

344

1.46

1.80

1.7

1.6

—

(1002224) Polysomnography panel

120

949

1.27

1.79

1.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

138

1.74

1.79

2.8

1.7

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

138

1.74

1.79

2.8

1.7

—

(4015189)

109

1.84

1.77

3.1

2.0

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

102

1.87

1.76

7.3

6.6

53.8

73.5

1.98

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

2.23

1.73

1.5

1.3

—

(3042631) Mycobacterium sp identified in Specimen

516

1.36

1.73

3.3

2.7

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

163

1.66

1.71

1.1

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

1.88

1.70

2.7

2.2

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

171

1.64

1.70

1.0

1.1

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

693

1.31

1.67

1.3

1.2

mmol/l

3.9

0.18

644

(3006245) CD3-CD19+ cells/100 cells in Blood

1.89

1.65

2.1

2.2

8.1

9.9

0.43

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

285

1.48

1.64

1.5

1.4

u/l

12.7

13.3

0.20

272

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

2.25

1.63

1.1

1.5

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

120

963

1.25

1.62

3.0

3.2

mmol/l

24.3

24.9

0.58

109

838

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.50

1.59

5.2

2.3

u/field

0.3

0.5

—

(3026480) Teichoate Ab [Titer] in Serum

2.50

1.59

1.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

602

1.32

1.59

1.3

iu/l

26.5

32.5

0.82

513

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.95

1.59

1.5

1.2

—

(3008536) Aspergillus sp Ab [Presence] in Serum

2.00

1.59

1.8

1.7

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.70

1.58

1.0

1.4

—

(3006653) Thiamine [Moles/volume] in Blood

167

1.62

1.58

1.3

1.2

nmol/l

130.1

140.9

0.83

167

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

144

1.67

1.57

1.2

—

(3032057) Clostridioides difficile [Presence] in Stool

1.93

1.54

1.7

2.0

—

(1761482) Bacteria [#/volume] in Urine by Culture

115

926

1.25

1.52

4.7

4.4

—

(3016018) Differential panel - Cerebral spinal fluid

307

1.44

1.51

1.8

1.4

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

2.60

1.51

1.3

1.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

2.86

1.50

1.0

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

210

1.53

1.48

2.2

1.8

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

125

1022

1.23

1.46

1.7

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

655

1.29

1.45

2.2

1.7

iu/l

7.5

4.4

0.87

199

(3001019) Free T4 and TSH panel - Serum or Plasma

110

887

1.25

1.45

1.7

—

(3019832) Treponema pallidum Ab [Presence] in Serum

132

1086

1.22

1.45

1.5

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

780

1.26

1.45

1.3

mg/l

476.2

559.0

1.93

729

(3034274) Bile acid [Moles/volume] in Serum --fasting

140

1.65

1.44

1.6

1.5

umol/l

4.9

11.4

0.79

(4268621)

277

1.45

1.44

2.5

2.4

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

3.13

1.44

3.2

5.8

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

2.73

1.43

1.0

1.3

ml/s/173m2

1.1

0.8

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

142

1.62

1.38

2.0

1.4

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

190

1.53

1.37

2.3

1.5

g/l

0.9

0.04

190

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

2.20

1.37

2.0

2.2

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

2.94

1.36

4.8

3.3

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

175

1.55

1.34

2.6

1.6

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

175

1.55

1.34

2.6

1.6

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

175

1.55

1.34

2.6

1.6

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

175

1.55

1.34

2.6

1.6

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

224

1.48

1.33

1.3

promille

1.6

1.1

0.95

171

(3001729) Color of Synovial fluid

0.00

1.32

0.0

1.5

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

1.76

1.28

2.1

2.2

24.5

29.9

0.92

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

2.09

1.27

1.3

1.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

2.29

1.26

1.0

—

(4212803)

2.29

1.26

1.1

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

277

1.41

1.26

1.3

1.6

u/ml

19.4

23.0

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

1.82

1.25

1.1

—

(3004809) Band form neutrophils/100 leukocytes in Blood

608

1.27

1.25

2.8

3.7

1.1

1.6

0.45

462

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

2.40

1.24

1.0

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.77

1.22

1.0

1.1

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

155

1.55

1.22

1.9

1.6

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1136

0.81

1.18

1.5

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

676

1.25

1.18

1.7

1.4

e6/l

6.4

23.9

1.18

523

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

676

1.25

1.18

1.8

1.4

e6/l

164.7

1020.0

2.58

551

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

214

1.45

1.18

2.0

2.1

18.2

14.8

0.62

(3029075) Extractable nuclear Ab panel - Serum

1.78

1.16

1.1

1.0

—

(3045142) Bone marrow Pathology biopsy report

420

1.31

1.16

1.2

1.3

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

2.50

1.15

1.2

1.1

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

2.50

1.15

1.4

—

(46235168) Fasting glucose [Moles/volume] in Blood

0.00

1.15

0.0

1.5

—

8.4

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

0.00

1.14

0.0

1.5

—

0.7

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

183

1.48

1.13

1.1

u/ml

0.7

2.8

—

(1616796) Gas panel - Central venous blood

100

827

1.22

1.11

4.3

3.9

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.26

1.10

1.0

1.3

u/l

8.6

12.8

—

(3024316) Viscosity of Plasma

2.38

1.09

2.2

1.4

mpas

1.6

1.9

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

2.19

1.08

1.0

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

166

0.54

1.07

1.6

1.3

mmol/l

5.7

6.1

—

155

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

541

1.26

1.07

1.1

1.2

—

(3045716) Anion gap in Serum or Plasma

180

0.55

1.06

1.3

2.3

mmol/l

8.7

9.1

—

141

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.12

1.05

1.4

1.2

—

(4027681)

137

1.54

1.05

1.2

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

129

1.55

1.05

1.2

1.3

—

(3023410) Appearance of Cerebral spinal fluid

297

1.35

1.04

2.1

1.5

—

(3011648) Oxygen content in Venous blood

280

1.36

1.03

2.5

1.8

11.0

10.9

0.03

280

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

2.27

1.03

1.0

1.1

—

(3002619) Bacteria identified in Specimen by Culture

1.84

1.02

1.5

1.1

—

(3015183) Erythrocyte sedimentation rate

106

1.61

1.02

1.5

1.2

—

(1175426) CD3 cells/100 lymphocytes in Blood

221

1.41

1.02

2.1

68.5

71.7

0.60

207

(3027923) C peptide [Moles/volume] in Serum or Plasma

171

1.47

1.02

1.2

1.3

nmol/l

1.1

0.10

128

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.69

1.01

1.1

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

147

1.50

1.00

1.1

u/l

0.9

1.2

3.07

(21494815) CD4 cells/100 lymphocytes in Specimen

239

1.38

1.00

2.2

2.0

21.8

43.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

1.81

0.98

1.2

1.1

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

1.63

0.97

7.5

1.8

ug/l

0.7

1.2

1.31

(3043410) Blood group antigens tested for on Red Blood Cells

1.63

0.97

1.5

2.1

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

460

1.27

0.96

2.7

2.4

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.65

0.94

1.1

1.0

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.89

0.94

1.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.22

0.93

1.2

1.1

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

178

1572

1.14

0.93

6.0

5.3

1.7

1.6

0.81

167

1473

(3041096) Erythrocytes [Presence] in Urine by Automated

754

7954

0.93

4.5

3.5

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

1.82

0.92

1.1

1.8

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

2.07

0.89

1.0

1.9

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.91

0.88

1.0

1.1

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

119

1.52

0.88

2.2

2.4

umol/l

76.2

148.8

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

307

1.31

0.87

2.1

1.5

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.00

0.87

1.2

1.0

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

168

0.59

0.86

1.2

1.1

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

136

1.47

0.86

1.1

1.2

ratio

1.0

1.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

195

1.39

0.86

1.7

1.3

u/ml

1.3

1.2

0.04

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

159

1797

0.88

0.85

2.0

1.8

—

(3035285) Chloride [Moles/volume] in Venous blood

471

1.24

0.82

2.7

2.4

mmol/l

105.7

105.5

0.11

463

(3041354) Potassium [Moles/volume] in Venous blood

471

1.24

0.82

2.7

2.4

mmol/l

4.0

4.1

0.41

463

(3028717) Thiamine [Mass/volume] in Blood

1.88

0.81

1.0

1.3

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

391

3636

1.08

0.80

4.1

3.7

—

(21494755) Public health laboratory ask at order entry panel

135

1533

0.88

0.79

1.4

—

(3025130) Human papilloma virus identified in Specimen

207

1.36

0.79

1.6

1.7

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

0.00

0.79

0.0

1.1

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.82

0.79

1.0

—

(3008295) Osmolality of Serum or Plasma

357

1.26

0.78

1.3

mosm/kgh2o

278.9

276.6

0.23

269

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

393

1.25

0.78

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.56

0.78

1.1

—

(3034426) Prothrombin time (PT)

1.56

0.78

1.3

—

(3016330) Potassium [Moles/time] in 24 hour Urine

1.77

0.76

1.0

1.2

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

166

1.39

0.75

1.1

1.0

u/ml

0.1

0.4

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

2.08

0.74

2.0

1.7

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

173

1554

1.12

0.73

6.2

5.3

0.9

0.72

163

1458

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.84

0.73

1.4

1.5

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.84

0.73

1.1

1.0

—

(3025315) Body weight

2.00

0.72

8.0

4.4

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.80

0.72

1.0

1.1

—

(3022689) Creatine [Moles/volume] in Urine

1.52

0.72

1.5

1.6

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

142

1.41

0.72

2.4

2.1

umol/l

63.3

54.9

0.38

111

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

110

0.54

0.72

1.5

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

110

0.54

0.72

1.5

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

110

0.54

0.72

1.5

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

110

0.54

0.72

1.5

1.4

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

407

1.23

0.71

1.8

1.6

—

(21491868) Cryoglobulin [Mass/volume] in Serum

117

1.46

0.71

1.2

1.3

—

0.2

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.75

0.71

1.1

1.0

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

145

0.62

0.69

1.0

1.2

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

195

1.34

0.69

1.1

nmol/l

4.4

8.2

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

230

1.31

0.69

1.0

1.3

—

(3004775) Volume in Urine collected for unspecified duration

301

1.27

0.69

2.5

2.2

693.3

634.5

0.46

185

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

751

1.16

0.68

1.8

1.7

—

(3050794) Legionella sp Ab [Presence] in Serum

1.79

0.66

1.2

1.1

—

(3022621) pH of Urine by Test strip

236

2170

1.09

0.66

4.3

3.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

1.51

0.66

1.2

1.1

miu/ml

2147.9

1734.6

0.46

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.61

0.65

1.6

ng/l

99.9

157.5

—

(3000330) Specific gravity of Urine by Test strip

196

1789

1.10

0.64

4.5

3.5

—

(3044290) Cell count panel - Cerebral spinal fluid

617

1.17

0.63

1.7

1.3

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

479

1.19

0.62

1.2

1.1

iu/ml

45.8

61.8

0.17

(3000034) Microalbumin [Mass/volume] in Urine

335

1.23

0.59

4.4

3.2

mg/l

95.7

32.8

0.57

260

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.46

0.58

1.1

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

116

0.60

0.57

1.4

2.4

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

116

0.60

0.57

1.4

2.4

—

(3000285) Sodium [Moles/volume] in Blood

1.48

0.57

1.0

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

283

1.24

0.56

1.2

1.5

—

(3014891) Appearance of Pleural fluid

1.46

0.56

1.4

1.7

—

(3005033) Fetal Nuchal fold Thickness US

0.57

0.56

1.6

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

0.57

0.56

1.6

1.4

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.62

0.55

1.3

1.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

1.58

0.54

1.0

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.58

0.54

1.0

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.46

0.54

1.1

—

(3016879) Cocaine [Presence] in Urine

349

1.21

0.53

1.2

1.5

—

(1617658) Protocol used for examination of sentinel lymph nodes

227

0.75

0.53

1.0

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

305

0.79

0.53

1.4

1.5

—

(3044242) Glucose [Moles/volume] in Arterial blood

203

0.74

0.51

4.1

2.1

—

(3024869) Neuronal Ab [Presence] in Serum

1.41

0.51

1.0

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.41

0.51

1.6

—

(40767503) Oxygen content in Capillary blood by calculation

809

0.88

0.50

2.7

2.5

16.2

16.0

0.13

420

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.52

0.48

1.0

1.2

—

(40768795) Lymph node Pathology biopsy report

308

1.20

0.48

1.1

1.2

—

(4281824)

308

1.20

0.48

1.1

1.2

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

327

1.19

0.47

1.7

1.5

22.6

27.1

0.48

197

(3018572) Chloride [Moles/volume] in Blood

853

1.12

0.47

7.8

7.2

mmol/l

105.7

105.1

0.69

761

(3039000) Anion gap in Blood

853

1.12

0.47

7.8

7.2

mmol/l

11.4

11.2

0.18

761

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.41

0.46

3.1

2.4

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.46

0.46

1.1

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

120

1.33

0.46

1.3

1.2

ug/l

240.7

397.6

—

(3050129) First trimester maternal screen panel - Serum or Plasma

120

0.67

0.45

1.3

1.5

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

0.59

0.45

1.0

1.5

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

1.37

0.44

1.6

1.4

58.7

75.6

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.61

0.43

1.0

1.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

0.65

0.42

1.5

—

(3025549) Creatine [Moles/time] in 24 hour Urine

1.56

0.42

1.8

1.4

—

(3035933) Granulocytes/100 leukocytes in Blood

1.40

0.42

1.1

1.8

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

1.52

0.41

1.4

1.3

mmol/l

—

(40758358) Immune stain study

0.00

0.41

0.0

1.0

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

643

1.12

0.40

1.4

1.3

—

(3027944) Amphetamines [Presence] in Urine

370

1.16

0.40

1.2

1.5

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

0.00

0.40

0.0

1.5

—

23.7

—

(40765096) Chromosome analysis panel by Banding

123

1.30

0.40

1.2

1.1

—

(3011288) Drugs identified in Urine by Screen method

241

1.20

0.40

1.4

2.1

—

(3046861) Legionella sp Ag [Presence] in Urine

0.00

0.40

0.0

1.0

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

418

1.15

0.39

1.8

1.5

55.9

61.6

0.47

254

(3011544) Albumin [Mass/volume] in Pleural fluid

1.43

0.39

1.0

1.1

g/l

14.1

16.2

—

(3002179) Metamyelocytes/100 leukocytes in Blood

244

2578

0.94

0.38

3.6

3.9

0.5

0.6

0.69

609

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

1.39

0.38

3.2

4.6

ug/min

90.8

67.1

—

(3000764) Benzodiazepines [Presence] in Urine

373

1.15

0.37

1.2

1.5

—

(3024263) Appearance of Synovial fluid

197

1.22

0.37

1.8

1.6

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.31

0.37

1.1

1.2

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

114

0.70

0.37

1.6

1.5

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.36

0.36

1.1

1.0

—

(3027008) Opiates [Presence] in Urine

375

1.15

0.36

1.2

1.4

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

632

1.11

0.35

4.4

3.7

61.1

58.0

1.21

632

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

145

0.76

0.34

1.3

1.4

—

1.4

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.36

0.34

1.0

1.2

—

(3028300) Cannabinoids [Presence] in Urine

377

1.14

0.34

1.2

1.4

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

146

1.23

0.32

1.2

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

208

0.82

0.31

1.8

1.6

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.32

0.30

1.0

1.2

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

357

0.87

0.30

1.2

mmol/l

8.3

7.6

0.43

260

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

1.29

0.30

1.6

1.2

nmol/l

72.0

126.5

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.32

0.28

1.2

1.1

—

(3052592) Norovirus Ag [Presence] in Stool

1.25

0.27

1.8

1.4

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

489

0.90

0.26

2.3

32.3

32.8

0.38

484

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

132

1.21

0.25

1.3

1.1

—

(3017181) Myelocytes/100 leukocytes in Blood

294

2837

1.04

0.25

3.9

4.1

1.0

0.9

0.15

104

852

(3025159) Blasts/100 leukocytes in Blood

243

2525

0.96

0.24

4.0

4.1

0.0

0.3

1.10

661

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.32

0.23

1.6

1.3

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.28

0.23

1.8

1.5

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

209

1.15

0.22

1.1

1.2

mmol/l

12.5

12.0

0.19

(3004451) EKG impression Narrative

181

1.16

0.22

1.4

1.3

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

0.74

0.22

1.1

1.4

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

0.21

0.0

1.1

—

1.3

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.3

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1.16

0.21

1.2

1.6

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.24

0.21

1.2

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

113

0.80

0.20

1.3

1.1

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

269

1.12

0.19

1.0

ng/l

301.1

320.1

0.21

181

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

193

1.14

0.19

5.0

3.7

—

(4198724)

1.15

0.19

1.0

1.5

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

217

0.87

0.18

1.3

1.5

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

217

0.87

0.18

1.3

1.5

—

(21494814) CD8 cells/100 lymphocytes in Specimen

128

1.17

0.18

2.0

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

271

1.11

0.18

1.0

ng/l

825.4

667.8

0.86

176

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

271

1.11

0.18

1.0

ng/l

60.9

45.9

0.37

179

(3051101) Glucose [Moles/volume] in Cord blood

1.15

0.17

3.1

6.2

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

110

1.18

0.17

1.5

1.9

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

0.73

0.17

2.0

3.2

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

0.73

0.17

1.0

1.2

mg/l

780.5

73.9

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

1.18

0.16

1.8

1.6

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

101

1.19

0.16

1.3

1.2

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

158

1.14

0.16

2.8

1.6

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

0.79

0.15

1.8

1.7

—

(44806420)

121

1.16

0.15

2.5

2.4

—

(3023511) Choriogonadotropin [Units/volume] in Urine

112

1.16

0.14

1.2

1.3

—

(3027315) Oxygen [Partial pressure] in Blood

822

1.05

0.14

6.3

4.8

kpa

8.3

8.4

0.24

808

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

188

0.90

0.11

1.5

1.4

pmol/l

55.9

206.5

—

(3016228) CD19 cells/100 cells in Blood

135

1.11

0.09

2.1

2.0

11.9

8.5

0.37

128

(3040151) Glucose [Moles/volume] in Capillary blood

409

1.05

0.09

8.4

6.3

mmol/l

7.0

7.4

0.66

340

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

1.03

0.08

1.8

1.2

u/l

37.8

609.5

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.06

0.08

1.4

—

(4133840)

1.06

0.08

1.4

1.2

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

0.84

0.07

7.0

7.6

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

0.86

0.07

1.2

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

0.82

0.07

1.3

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

0.83

0.07

2.3

3.1

—

(3010421) pH of Blood

956

1.03

0.07

5.9

4.6

7.4

0.04

804

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.03

0.07

5.4

7.8

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

100

0.90

0.06

5.4

7.6

—

(40768800) Prostate Pathology biopsy report

942

0.98

0.06

1.3

1.2

—

(40768793) Breast Pathology biopsy report

641

1.03

0.06

1.2

1.3

—

(3021901) Oxygen saturation in Capillary blood

711

1.03

0.06

2.4

2.8

—

(3028707) Methadone [Presence] in Urine by Screen method

169

1.07

0.05

1.2

1.7

—

(3017569) Oxygen content in Arterial blood

189

1.06

0.04

4.1

2.3

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

111

1.08

0.04

1.0

1.1

u/ml

—

10.8

—

(3003740) Influenza virus B Ag [Presence] in Specimen

279

1.04

0.04

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

280

1.04

0.03

1.1

—

(3021440) Promyelocytes/100 leukocytes in Blood

267

2688

0.99

0.03

4.0

4.1

0.2

0.1

0.61

790

(3035320) C reactive protein [Mass/volume] in Body fluid

231

1.04

0.02

1.8

2.5

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

113

1.06

0.01

1.2

1.3

—

(3000012) Reticulocyte production index

193

1.04

0.01

1.3

1.5

—

(3019977) pH of Arterial blood

214

1.03

0.00

3.9

2.6

7.4

0.51

(3039443) Prostate specific Ag panel - Serum or Plasma

618

1.00

0.00

1.7

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

852

1.00

0.00

1.5

1.7

mg/l

4.0

3.6

0.09

613

(3047181) Lactate [Moles/volume] in Blood

116

1164

1.00

0.00

7.4

6.4

mmol/l

1.3

0.05

106

1031

(3012501) Base excess in Blood by calculation

816

1.01

0.00

6.3

4.8

mmol/l

3.2

2.7

0.85

566

(3014051) Protein [Presence] in Urine by Test strip

784

0.99

0.00

2.6

2.3

—

(3013290) Carbon dioxide [Partial pressure] in Blood

817

1.00

0.00

6.4

4.8

kpa

5.1

5.0

0.54

804

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

127

1.02

0.00

1.3

1.1

iu/ml

200.9

208.5

0.06

127

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

237

1.01

0.00

1.3

1.2

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

253

0.99

0.00

1.4

1.5

—

(3014271) Vancomycin [Susceptibility]

207

1.01

0.00

2.6

3.0

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.0

1.4

—

2.1

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

1.4

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

0.00

0.0

1.1

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.0

1.0

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

0.0

1.1

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.0

1.0

—

(3040893) Potassium [Moles/volume] in Capillary blood

0.00

0.0

2.0

—

4.7

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.01

0.00

1.0

1.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

0.90

0.00

1.0

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

0.99

0.00

1.0

1.3

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.90

0.00

1.3

1.1

—

(3034614) HLA Ag [Interpretation]

0.00

0.0

1.2

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

0.96

0.00

1.1

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

0.96

0.00

1.1

1.0

—

(36303858) Crystals [Presence] in Urine

0.00

0.0

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

0.00

0.0

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

0.96

0.00

1.1

1.0

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3038385) Creatinine [Moles/volume] in Peritoneal fluid

0.00

0.0

1.5

—

167.0

—

(3013637) Mi-2 Ab [Presence] in Serum

0.96

0.00

1.1

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3009871) Measles virus Ab [Titer] in Serum

0.97

0.00

1.4

1.5

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

0.00

0.0

1.2

—

3776.0

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

0.0

1.0

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.0

1.0

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint CD2_BENIGN_TRANSVERSE_COLON and mortality.

Females

Parameter	HR [95% CI]	p-value
CD2_BENIGN_TRANSVERSE_COLON	1.299 [1.16, 1.46]	< 0.001
Birth year	1.0 [0.99, 1.01]	0.947

During the follow-up period (1.1.1998 — 31.12.2019), 1139 out of 5873 females with CD2_BENIGN_TRANSVERSE_COLON died.

Males

Parameter	HR [95% CI]	p-value
CD2_BENIGN_TRANSVERSE_COLON	1.36 [1.21, 1.53]	< 0.001
Birth year	0.983 [0.97, 0.99]	< 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 2006 out of 7240 males with CD2_BENIGN_TRANSVERSE_COLON died.

Mortality risk

Mortality risk for people of age

years, who have CD2_BENIGN_TRANSVERSE_COLON.

N-year risk	Females	Males
1	0.122%	0.234%
5	0.829%	1.35%
10	2.124%	3.367%
15	4.219%	6.235%
20	7.572%	10.785%

Relationships between endpoints

↥

Index endpoint: CD2_BENIGN_TRANSVERSE_COLON – Benign neoplasm: Transverse colon

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Benign neoplasm: Transverse colon

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints